Movatterモバイル変換


[0]ホーム

URL:


US10500038B1 - Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valve - Google Patents

Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valve
Download PDF

Info

Publication number
US10500038B1
US10500038B1US13/475,994US201213475994AUS10500038B1US 10500038 B1US10500038 B1US 10500038B1US 201213475994 AUS201213475994 AUS 201213475994AUS 10500038 B1US10500038 B1US 10500038B1
Authority
US
United States
Prior art keywords
annulus
ventricle
mitral valve
valve
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US13/475,994
Inventor
Boris Orlov
Ehud Raanani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tel HaShomer Medical Research Infrastructure and Services Ltd
Original Assignee
Tel HaShomer Medical Research Infrastructure and Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tel HaShomer Medical Research Infrastructure and Services LtdfiledCriticalTel HaShomer Medical Research Infrastructure and Services Ltd
Priority to US13/475,994priorityCriticalpatent/US10500038B1/en
Assigned to TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.reassignmentTEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: ORLOV, BORIS, RAANANI, Ehud
Priority to US16/655,656prioritypatent/US11583394B2/en
Application grantedgrantedCritical
Publication of US10500038B1publicationCriticalpatent/US10500038B1/en
Priority to US18/103,671prioritypatent/US12208003B2/en
Priority to US18/999,207prioritypatent/US20250120805A1/en
Activelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Images

Classifications

Definitions

Landscapes

Abstract

According to an aspect of some embodiments of the invention, there is provided a method of deploying an expandable prosthetic mitral valve in a subject, the method comprising: deploying a first component of the prosthetic mitral valve in a left atrium; deploying a second component of the prosthetic mitral valve in a left ventricle; and approximating the first and the second components so that leaflets of a native mitral valve are trapped between the first and the second components.

Description

RELATED APPLICATION
This application claims the benefit of priority under 35 USC 119(e) of U.S. Provisional Patent Application No. 61/488,180 filed May 20, 2011, the contents of which are incorporated herein by reference in their entirety.
FIELD AND BACKGROUND OF THE INVENTION
The present invention relates to the field of cardiac surgery, and more particularly to the field of prosthetic heart valves, especially prosthetic mitral valves.
Thehuman heart10, depicted in cross-sectional long axis view inFIG. 1A (during diastole) and1B (during systole), is a muscular organ that pumps deoxygenated blood through the lungs to oxygenate the blood and pumps oxygenated blood to the rest of the body by rhythmic contractions of four chambers.
After having circulated in the body, deoxygenated blood from the body enters rightatrium12 throughvena cava14.Right atrium12 contracts, pumping the blood through atricuspid valve16 intoright ventricle18,FIG. 1A.Right ventricle18 contracts, pumping the blood through a pulmonarysemi-lunar valve20 into thepulmonary artery22 which splits to two branches, one for each lung,FIG. 1B. The blood is oxygenated while passing through the lungs and reenters the heart to theleft atrium24.Left atrium24 contracts, pumping the oxygenated blood through themitral valve26 into theleft ventricle28,FIG. 1A.Left ventricle28 contracts, pumping the oxygenated blood through theaortic valve30 into theaorta32 to be distributed to the rest of the body,FIG. 1B.
Inmitral valve26, an approximately circular mitral annulus34 defines amitral valve orifice36. Attached to the periphery ofmitral annulus34 is ananterior leaflet38 and a smallerposterior leaflet40,leaflets38 and40 connected topapillary muscles44 at the bottom ofleft ventricle28 bychordae46. The typical area of the mitral lumen in a healthy adult is between 4 and 6 cm2while the typical total surface area ofleaflets38 and40 is significantly larger, approximately 12 cm2.
During diastole depicted inFIG. 1A,left atrium24 contracts to pump blood intoleft ventricle28 throughorifice36 ofmitral valve26. The blood flows throughorifice36, pushingleaflets38 and40 intoleft ventricle28 with little resistance. The leaflets ofaortic valve30 are kept closed by blood pressure inaorta32.
During systole, depicted inFIG. 1B,left ventricle28 contracts to pump blood intoaorta32 throughaortic valve30 which leaflets are pushed open by the blood flow with relatively little resistance. Mitral annulus34 contracts, pushingleaflets38 and40 inwards and reducing the area ofmitral valve orifice36 by about 20% to 30%.Papillary muscles44 contract, maintaining the tension ofchordae46 and pulling the edges ofleaflets38 and40, preventing prolapse ofleaflets38 and40 intoleft atrium24.Leaflets38 and40 curve intoleft ventricle28 and coapt to accommodate the excess leaflet surface area, producing acoaptation surface42 that constitutes a seal. The typical length ofcoaptation surface42 in ahealthy heart10 of an adult is approximately 7-8 mm. The pressure of blood inleft ventricle28 pushes against the ventricular surfaces ofleaflets38 and40, tightly pressingleaflets38 and40 together atcoaptation surface42 so that a tight leak-proof seal is formed.
An effective seal ofmitral valve26 during ventricular systole is dependent on a sufficient degree of coaptation, in terms of length, area and continuity ofcoaptation surface42. Ifcoaptation surface42 is insufficient or non-existent, there is mitral valve insufficiency, that is, regurgitation of blood fromleft ventricle28 intoleft atrium24 during ventricular systole. A lack of sufficient coaptation may be caused by any number of physical anomalies that allow leaflet prolapse (e.g., elongated or rupturedchordae46, weak papillary muscles44) or prevent coaptation (e.g.,short chordae46,small leaflets38 and40). There are also pathologies that lead to a mitral valve insufficiency including collagen vascular disease, ischemic mitral regurgitation (resulting, e.g., from myocardial infarction, chronic heart failure, or failed/unsuccessful surgical or catheter revascularization), myxomatous degeneration ofleaflets38 and40 and rheumatic heart disease. Mitral valve insufficiency leads to many complications including arrhythmia, atrial fibrillation, cardiac palpitations, chest pain, congestive heart failure, fainting, fatigue, low cardiac output, orthopnea, paroxysmal nocturnal dyspnea, pulmonary edema, shortness of breath, and sudden death.
Apart from humans, mammals that suffer from mitral valve insufficiency include horses, cats, dogs, cows, sheep and pigs.
It is known to use open-heart surgical methods to treat mitral insufficiency, for example by modifying the subvalvular apparatus (e.g., lengthening or shortening chordae46) to improve leaflet coaptation, implanting an annuloplasty ring to forcemitral valve annulus34 into a normal shape.
Aortic valves are known to suffer from aortic insufficiency or aortic stenosis. It is known to deploy a prosthetic aortic valve using minimally invasive surgery to replace a malfunctioning native aortic valve. Typically, an expandable frame (e.g., a stent or a ring) supporting artificial aortic leaflets is positioned inside the orifice of an aortic valve, typically endovascularly with a catheter passing through the aorta, but also transapically through a hole near the apex of the heart, passing intoleft ventricle28. The frame is expanded across the aortic annulus folding and overlying the native aortic valve leaflets, maintaining the prosthetic aortic valve in place by exertion of an axial force and by adopting an “hourglass” shape that distributes axial forces on the native aortic valve annulus and the surrounding tissue. Commercially available prosthetic aortic valves include the Lotus™ by Sadra Medical (Campbell, Calif., USA) and the CoreValve™ by Medtronic (Minneapolis, Minn., USA).
It has been suggested to deploy a prosthetic mitral valve, analogous to a prosthetic aortic valve. A challenge to implementing such suggestions is retention of the prosthesis in place during ventricular systole. Unlike the aortic valve annulus that constitutes a stable anchoring feature, especially when calcified, the mitral valve annulus is not a sufficiently stable anchoring feature (less than half of the mitral valve annulus is of fibrotic tissue) and is dynamic (changing size and shape as the heart beats). Further, unlike the aortic valve that is open during ventricular systole, the mitral valve must withstand the high pressures in the left ventricle caused by contraction of the left ventricle during ventricular systole, pressures that tend to force a mitral valve prosthesis deployed across a mitral valve annulus into the left atrium.
Additional background art includes US Application No. 2011/0137397 by Chau et al., which discloses “Embodiments of prosthetic valves for implantation within a native mitral valve are provided. A preferred embodiment of a prosthetic valve includes a radially compressible main body and a one-way valve portion. The prosthetic valve further comprises at least one ventricular anchor coupled to the main body and disposed outside of the main body. A space is provided between an outer surface of the main body and the ventricular anchor for receiving a native mitral valve leaflet.”
SUMMARY OF THE INVENTION
An aspect of some embodiments of the invention relates to prosthetic heart valve. Optionally, to prosthetic mitral valves. Some embodiments of the invention relate to methods and devices suitable for deploying prosthetic heart valves. Optionally, prosthetic mitral valves.
According to an aspect of some embodiments of the invention, there is provided a method of deploying an expandable prosthetic mitral valve in a subject, the method comprising:
deploying a first component of the prosthetic mitral valve in a left atrium;
deploying a second component of the prosthetic mitral valve in a left ventricle; and
approximating the first and the second components so that leaflets of a native mitral valve are trapped between the first and the second components.
In an exemplary embodiment of the invention, approximating comprises approximating by pulling a wire connecting the first and the second elements.
In an exemplary embodiment of the invention, the method further comprises joining said first and second elements to maintain an approximated position.
In an exemplary embodiment of the invention, approximating comprises tightly trapping the native mitral valve leaflets.
In an exemplary embodiment of the invention, the method further comprises piercing said leaflets by at least one of the first or the second components.
In an exemplary embodiment of the invention, the method further comprises piercing tissues surrounding said leaflets by at least one of said first or said second components.
According to an aspect of some embodiments of the invention, there is provided a prosthetic mitral valve suitable for deployment in a mammalian heart, comprising:
a) an annulus part defining a prosthetic mitral valve lumen and having a proximal portion, the annulus part having a deployed configuration configured for deployment inside a left atrium of a heart wherein the proximal portion passes into the mitral valve annulus of the heart; and
b) a ventricle part, configured for deployment in a left ventricle of a heart having a deployed configuration configured for at least partially encircling the proximal portion of the annulus part.
According to an aspect of some embodiments of the invention, there is also provided a deployment device for transapically deploying a prosthetic mitral valve contained therein, comprising:
a) a substantially tubular delivery housing including a delivery lumen having an opening at a distal end thereof, the delivery housing configured for transapical entry into a mammalian heart, distal end first;
b) inside the delivery lumen, an annulus part of a prosthetic mitral valve defining a prosthetic mitral valve lumen and having a proximal portion, in a compact delivery configuration, the annulus part outwardly radially expandable subsequent to release from the delivery housing to a deployed configuration configured for deployment inside a left atrium of a heart in which deployed, wherein the proximal portion passes into the mitral valve annulus of the heart;
c) inside the delivery lumen, proximally from the annulus part, a ventricle part of the prosthetic mitral valve physically separate from the annulus part, in a compact delivery configuration, the ventricle part outwardly radially expandable subsequent to release from the delivery housing to a deployed configuration configured for deployment in a left ventricle of a heart at least partially encircling the proximal portion of the annulus part;
d) an annulus-part release component allowing release of the annulus part through the distal end of the delivery housing;
e) a ventricle-part release component allowing release of the ventricle part through the distal end of the delivery housing; and
f) a joining component functionally associated with the annulus part and the ventricle part, the joining component configured to bring the annulus part and the ventricle part together when the annulus part is in the deployed configuration subsequent to release from the delivery housing, allowing deployment of the prosthetic mitral valve in a heart.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. In case of conflict, the specification, including definitions, will control.
As used herein, the terms “comprising”, “including”, “having” and grammatical variants thereof are to be taken as specifying the stated features, integers, steps or components but do not preclude the addition of one or more additional features, integers, steps, components or groups thereof. These terms encompass the terms “consisting of” and “consisting essentially of”.
As used herein, the indefinite articles “a” and “an” mean “at least one” or “one or more” unless the context clearly dictates otherwise.
BRIEF DESCRIPTION OF THE FIGURES
Some embodiments of the invention are herein described with reference to the accompanying figures. The description, together with the figures, makes apparent to a person having ordinary skill in the art how some embodiments of the invention may be practiced. The figures are for the purpose of illustrative discussion and no attempt is made to show structural details of an embodiment in more detail than is necessary for a fundamental understanding of the invention. For the sake of clarity, some objects depicted in the figures are not to scale. In the Figures:
FIGS. 1A and 1B schematically depict a normal adult human heart in cross-sectional long axis view during atrial systole (FIG. 1A) and during ventricular systole (FIG. 1B), to help understand some embodiments of the invention;
FIG. 2A depicts the annulus part and the ventricle part of an embodiment of a prosthetic mitral valve as described herein, in a compact delivery configuration, in accordance with an exemplary embodiment of the invention;
FIG. 2B depicts the annulus part and the ventricle part of the prosthetic mitral valve ofFIG. 2A, in a deployed configuration, in accordance with an exemplary embodiment of the invention;
FIG. 3 schematically depicts an embodiment of a deployment device useful for deploying a prosthetic mitral valve ofFIGS. 2A and 2B in side cross section, in accordance with an exemplary embodiment of the invention;
FIGS. 4A-4H depict the deployment of a prosthetic mitral valve using the deployment device ofFIG. 3, in accordance with an exemplary embodiment of the invention;
FIGS. 5A-5G depict the deployment of an additional embodiment of a prosthetic mitral valve, in accordance with some embodiments of the invention;
FIG. 6 is a flowchart of a method of deploying the prosthetic mitral valve, in accordance with an exemplary embodiment of the invention; and
FIG. 7 is flowchart of a method of treating a patient by mitral valve replacement, in accordance with an exemplary embodiment of the invention.
DESCRIPTION OF SOME EMBODIMENTS OF THE INVENTION
An aspect of some embodiments of the invention relates to prosthetic heart valves. Optionally, to prosthetic mitral valves. Some embodiments of the invention relate to methods and devices suitable for deploying prosthetic heart valves. Optionally, prosthetic mitral valves.
An aspect of some embodiments of the invention relates to a method of deploying a prosthetic mitral valve comprises; deploying a first prosthetic mitral valve portion against the left atrial surface of the mitral valve leaflets, deploying a second prosthetic mitral valve portion inside a left ventricle, and approximating the first and second portions so that the mitral valve leaflets are trapped between the first and second portions. Optionally, at least one wire connected the first and second portions is used to guide the second portion towards the first portion. Alternatively, the wire is used to guide the first portion towards the second portion. Alternatively, the wire is used to close the distance between the first and second portions.
In an exemplary embodiment of the invention, anchoring is performed only to the leaflets, for example, the annular part and the ventricle part are placed on opposite sides of the leaflets and apply force to hold tightly to the leaflets. Alternatively, at least some support is provided by the surrounding tissues, for example, the annulus part extends outwards against the fibrous ring and/or walls of the left atrium. Potentially, the extending outwards of the annulus part prevents or reduces migration of the valve into the left ventricle.
In an exemplary embodiment of the invention, top and bottom portions are joined to one another. Optionally, the joining is performed by elements that bend and/or clasps.
In an exemplary embodiment of the invention, the first and second portion are joined and/or approximated so that the leaflets are clamped hard between the first and second portions. Potentially, the leaflets are clamped hard enough so that migration of the valve into the left atrium (e.g., during systole) is prevented and/or migration into the left ventricle (e.g., during diastole) is prevented. Optionally, the clamping is not hard enough to reduce blood flow to the leaflets to cause necrosis.
Optionally, a tether (e.g., as described below) is used to prevent or reduce migration of the valve.
In an exemplary embodiment of the invention, the pressure applied between the first and second portions to the leaflets is maintained by tension in the wire connecting the first and second portions. Alternatively or additionally, the force is maintained by the attachment elements connecting the first and second portions.
In an exemplary embodiment of the invention, the approximating does not need to be exact, as some tolerance is allowed. Optionally, the second portion is larger than the first portion, so that the second portion surrounds the leaflets and/or the first portion.
The principles, uses and implementations of the teachings of the invention may be better understood with reference to the accompanying description and figures. Upon perusal of the description and figures present herein, one skilled in the art is able to implement the teachings of the invention without undue effort or experimentation. In the figures, like reference numerals refer to like parts throughout.
Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth herein. The invention is capable of other embodiments or of being practiced or carried out in various ways. The phraseology and terminology employed herein are for descriptive purpose and should not be regarded as limiting.
A potential advantage of some embodiments of the invention, is retaining the deployed prosthetic mitral valve, especially during systole, against the generated high pressures in the left ventricle caused by contraction of the left ventricle, without forcing the prosthetic mitral valve into the left atrium.
In an exemplary embodiment of the invention a prosthetic mitral valve comprises two parts, an annulus part (e.g., for deployment in the left atrium) and a ventricle part (e.g., for deployment in the left ventricle).
In an exemplary embodiment of the invention, when deployed, the annulus part is deployed inside a left atrium across the mitral valve annulus (e.g., within the annulus). Optionally, the annulus part is deployed against the atrial aspect of the leaflets. Optionally or additionally, the annulus part is deployed within the native annulus against the leaflets so that the leaflets all or mostly lie inside the left ventricle (e.g., similar leaflet state as during diastole).
In an exemplary embodiment of the invention, the deployment occurs by retracting the expanded annulus part into the native mitral valve annulus. Alternatively, the annulus part is expanded within the native annulus.
In an exemplary embodiment of the invention, a proximal portion of the annulus part is sized and/or positioned so that the annulus part passes into (and in some embodiments through) the mitral valve annulus. Optionally, the proximal portion is sized and/or positioned to extend to about the edge of the native leaflets. Alternatively, the proximal portion is sized and/or positioned to extend past the edge of the native leaflets into the left ventricle.
In an exemplary embodiment of the invention, the ventricle part of the prosthetic mitral valve is deployed inside the left ventricle. Optionally, the ventricle part is displaced towards the mitral valve annulus (e.g., by pulling on the wire connecting the parts) so that the ventricle part at least partially encircles the proximal portion of the annulus part. For example about 360 degrees along the circumference, or about 345 degrees, or about 330 degrees, or about 315 degrees, or about 300 degrees, or about 270 degrees, or other smaller or intermediate dimensions. Potentially, the use of the partially encircling ventricle part does not require cutting the chords, as the partial circumference ventricle part can be positioned even in the presence of the chords. Optionally, the ventricle part is fixed to the proximal portion of the annulus, for example, using anchoring elements, for example, bending elements.
In some embodiments, the ventricle part of the prosthetic mitral valve has a diameter about the same or larger than that of the native mitral valve orifice. For example, the diameter is about 1 mm larger, or about 3 mm, or about 5 mm, or about 7 mm, or about 10 mm, or other smaller, intermediate or larger diameters larger. Potentially, the larger diameter allows easier positioning of the ventricle part around the leaflets and/or annulus part.
In an exemplary embodiment, the ventricle part of the prosthetic mitral valve at least partially encircles the native mitral valve leaflets as well as the proximal portion of the annulus part of the prosthetic mitral valve, thereby trapping the leaflets between the ventricle and the annulus parts. Optionally, both mitral leaflets are encircled. Alternatively, one leaflet is fully encircled and one leaflet is at least partially encircled. Alternatively, one leaflet is at least partially encircled and one leaflet is not. Alternatively, none of the mitral leaflets are encircled, but the portion of the annulus part (e.g., proximal portion) extending into the left ventricle is at least partially encircled or fixed thereto.
Thereby the ventricle part of the prosthetic mitral valve acts substantially as a “locking ring”. Potentially, movement of the prosthetic mitral valve into the left atrium is prevented or significantly reduced, even during systole.
Exemplary Method of Treatment
FIG. 7 is a flowchart of a method of treating a patient in accordance with an exemplary embodiment of the invention. It should be noted that the figure is not necessarily limited to the method described below, for example, as some steps are optional and different devices can be used.
Optionally, at702, a patient is selected for minimally invasive or percutaneous mitral valve replacement, in accordance with an exemplary embodiment of the invention. The patient is selected, for example, by the treating physician. Some not necessarily limiting examples of patient indications include; non-surgical candidates, mitral valve prolapse, mitral valve stenosis,
In some embodiments, the heart is not stopped from beating during the procedure, even as the prosthetic valve is deployed. Potentially, patients can be treated that would otherwise be refused surgery. Alternatively, the beating of the heart is stopped for at least part of the duration of the procedure.
Optionally, at704, a suitable valve prosthesis adapted for anchoring to the leaflets is selected, in accordance with an exemplary embodiment of the invention. Further details about the valve are provided, for example, in the section “Exemplary Prosthetic Mitral Valve”.
Optionally, at706, the prosthetic valve is inserted into the body, in accordance with an exemplary embodiment of the invention. Optionally, a percutaneous approach is used. Optionally, one catheter is inserted into the body to deliver the single component or dual component valve. Alternatively, two catheters are inserted, each catheter delivering one piece of the two piece valve.
Some not necessarily limiting approaches include; femoral vein/jugular vein→right atrium→transseptal (e.g., punctured using a suitable needle or radiofrequency ablation device)→left atrium (→optional left ventricle); femoral artery→aorta→left ventricle (→optional left atrium).
Alternatively or additionally, a minimally invasive approach is used, for example, trans-apical. Alternatively or additionally, the open heart surgery approach is used.
Optionally, the patient is placed under general anesthesia. Alternatively, conscious sedation is used. Alternatively or additionally, local anesthesia is used.
In the case of the trans-apical approach, access to the left ventricular apex of the heart is gained, for example, through a left anterolateral mini-thoractomoy in the fifth intercostal space with horizontal opening of the pericardium and optionally placement of stay sutures for exposure. Optionally, a retractor is placed, exposing the heart apex. Optionally or additionally, two rows of 3-0 polpropylene pledgeted felt purse string sutures are placed around the left ventricular apex creating a 3-4 cm diameter area exposed for access. Optionally or additionally, a 4000 Units of heparin bolus is administered intravenously.
Optionally, at708, the mitral valve leaflets are identified. Optionally, a TEE (trans-esophageal echo) probe is positioned to observe the left ventricular long axis of the heart throughout the operation. Optionally or additionally, the TEE is used to visualize the chords.
Other not necessarily limiting imaging modalities can be used to identify the leaflets, for example, fluoroscopy.
At710, the first component of the valve is deployed, in accordance with an exemplary embodiment of the invention. For example, deployment occurs as described with reference toFIG. 8. Optionally, the first component is deployed in the left atrium.
Optionally, at712, the second component of the valve is deployed, in accordance with an exemplary embodiment of the invention. For example, deployment occurs as described with reference toFIG. 8. Optionally, the second component is deployed in the left ventricle.
Optionally, at716, the first and second components are approximated. Optionally or additionally, the first and second components are joined together. For example, as described with reference toFIG. 8.
Optionally, at714, the deployed prosthetic valve is evaluated. Optionally, the location of the valve is evaluated, for example, using one or more imaging modalities such as ultrasound. Optionally or additionally, the function of the valve is evaluated, for example, using one or more imaging modalities to visualize the blood flow such as Doppler ultrasound.
Exemplary Prosthetic Mitral Valve
Thus, according to an aspect of some embodiments of the invention there is provided a prosthetic mitral valve suitable for deployment in a mammalian heart, comprising:
a) an annulus part, defining a prosthetic mitral valve lumen and having a proximal portion, the annulus part having a deployed configuration configured for deployment inside a left atrium of a heart in which deployed wherein the proximal portion passes into (and in some embodiments, through) the mitral valve annulus; and
b) a ventricle part, configured for deployment in a left ventricle of a heart, the ventricle part having a deployed configuration configured for at least partially encircling the proximal portion of the annulus part.
In an exemplary embodiment of the invention, the annulus part and the ventricle part are physically separate components.
In an exemplary embodiment, the ventricle part is sized and/or shaped, in the deployed configuration, to at least partially encircle the native mitral valve leaflets of the heart in which deployed. In some embodiments the native mitral valve leaflets serve as a seal to reduce or prevent blood flow from regurgitating from the left ventricle to the left atrium during systole. Potentially, the bulk and complexity of the prosthetic cardiac valve is reduced, for example, by not requiring additional material to the annulus part to seal the valve against regurgitation of blood.
In an exemplary embodiment, in the deployed configuration the annulus part of the prosthetic mitral valve has a funnel shape, for example, having a narrower (axial dimension) proximal portion and a wider (axial dimension) distal portion. Alternatively, a cylinder shape is used. Optionally, when deployed in a heart, the wider distal portion rests against the inner walls of the left atrium in proximity of the native mitral valve annulus. Alternatively, the wider distal portion does not rest against the left atrium walls, and/or the fibrous ring, but rests only against the leaflets. For example, the distal portion is short or does not extend to the walls. Potentially the prosthetic mitral valve is prevented by the contact with the atrial walls from moving into the left ventricle, for example, during diastole.
In some embodiments, when deployed in a heart, the proximal portion of the annulus passes into the mitral valve annulus, and in some embodiments into the left ventricle, and in some embodiments even past the edges of the native mitral valve leaflets.
In an exemplary embodiment, in the deployed configuration the ventricle part of the prosthetic mitral valve is ring-shaped (a partial or a complete ring). The inner diameter of the ventricle part is sufficient to at least partially encircle the proximal portion of the annulus part, and in some embodiments, at least one of the native mitral valve leaflets of the heart are trapped by the encircling. Optionally, the ventricle part has a relatively small axial dimensions in the deployed configuration so as to have an unobtrusive low profile when deployed inside a left ventricle, potentially not substantially interfering with left ventricle functioning, for example by not partially occluding or causing turbulence in the vicinity of the aortic valve.
Valve Mechanism
In an exemplary embodiment, the annulus part of the prosthetic mitral valve includes a valve mechanism functionally associated with the prosthetic mitral valve lumen, for example, the valve is attached to the annulus part using one or more not necessarily limiting methods including; dip molded thereon, glue, sutures, crimped. Alternatively, the valve mechanism is attached to the ventricle part. Alternatively, the valve mechanism is at least partially attached to the annulus part and at least partially attached to the ventricle part, for example, one or more leaflets on the ventricle part and one or more leaflets on the annular part.
In some embodiments, the valve mechanism is suitable for functioning as a mitral valve even if not originally designed as a mitral valve replacement, that is to say, to prevent flow of blood from the left ventricle to the left atrium through the prosthetic mitral valve lumen during systole but to allow flow of blood from the left atrium to the left ventricle during diastole. The valve mechanism can be any suitable valve mechanism, some not necessarily limiting examples include mechanical valves such as; a bileaflet-mechanism (St. Jude mechanism), a caged-ball mechanism (e.g., Starr-Edwards mechanism), or a tilting-disc mechanism (e.g., Bjork-Shiley mechanism). Alternatively, in some embodiments, the valve mechanism is a biological and/or synthetic leaflet-valve mechanism including at least two leaflets, in some embodiments at least three leaflets. Optionally, valves designed for replacement of valves other than the mitral valve can be used, for example, aortic replacement valves. Not necessarily limiting examples include; Lotus™ or CoreValve™ mentioned above. Optionally, the valve mechanism, for example, the leaflet-valve mechanism, is located inside the prosthetic mitral valve lumen. Optionally, the valve mechanism is positioned within the prosthetic mitral valve lumen of the proximal portion, so that, when deployed, the valve mechanism is located within the native mitral valve annulus and/or inside the left ventricle of a heart in which deployed. Optionally, the position of the valve mechanism is positioned so that the trapped leaflets and the prosthetic valve mechanism acts as a seal to blood.
In some embodiments, the artificial valve mechanism, including leaflet-valve mechanism is configured so as not to be subject to prolapse into a left atrium as can happen with native mitral valve leaflets. In some embodiments where a valve mechanism includes leaflets that are potentially subject to prolapse, the prosthetic mitral valve optionally includes a prolapse-preventing component, for example as described in US 2002/0065554 and US 2004/0138745 or as implemented in the Endovalve (Endovalve Inc., Princeton, N.J., USA). Alternatively, where a valve mechanism includes leaflets that are potentially subject to prolapse, the prosthetic mitral valve optionally includes a prolapse-preventing component that is substantially an artificial chorda, for example as described in WO 2009/134701. Alternatively, no prolapse preventing component is used, for example if using a trileaflet valve design such as an aortic replacement valve.
Dynamic Conformation
In some embodiments, the annulus part of the prosthetic mitral valve is configured, (e.g., in the deployed configuration) to dynamically conform to the native mitral valve annulus and/or to the atrial walls in proximity of a native mitral valve of a heart in which deployed. For example, in some such embodiments, the annulus part is self-expanding and dimensioned to be slightly wider (radial dimension) than the native mitral valve annulus and/or atrial walls of the heart in which deployed so that the annulus part is biased to radially expand against the atrial walls and/or the native mitral valve annulus. Potentially, as the heart beats and the shape and/or dimensions of the atrial walls and/or of the native mitral valve annulus change (e.g., expansion and/or compression), the annulus part dynamically conforms, potentially assisting in maintaining a seal between the left atrium and left ventricle and/or allowing substantially natural movement of the heart. Optionally, the valve is made out of an elastic material which allows for the dynamic conformation, for example, Nitinol. Optionally or additionally, the valve is designed with one or more features that allow for expansion and/or contraction, for example, within the struts, one or more ‘S’, ‘Z’, or other similar shapes.
Expandable Annulus Part
In some embodiments, the annulus part is outwardly radially expandable from a compact delivery configuration to the deployed configuration. Optionally, the annulus part has a larger outer radius in the deployed configuration than in the delivery configuration, allowing minimally-invasive deployment of the prosthetic mitral valve, for example, transapically, percutaneously, for example with the help of a deployment device such as a delivery catheter or similar.
In some embodiments, the annulus part is expandable from the delivery configuration to the deployed configuration by application of a radially outwards force to an inner surface thereof, for example, with a catheter-mounted balloon that can be expanded and retracted, for example, by the operator outside of the body of the patient injecting fluid into the balloon. In one not necessarily limiting example, the annulus part is made out of a material that can be balloon expanded, for example, stainless steel 316L.
In some embodiments, the annulus part is self-expanding from the delivery configuration to the deployed configuration, for example, upon removal of an encasing sheath. In one not necessarily limiting example, the annulus part is made out of a memory material, for example, Nitinol.
Expandable Ventricle Part
In some embodiments, the ventricle part is outwardly radially expandable from a compact delivery configuration to the deployed configuration.
Optionally, the ventricle part has a larger outer radius in the deployed configuration than in the delivery configuration, allowing minimally-invasive deployment of the prosthetic mitral valve, for example, transapically, percutaneously, for example with the help of a deployment device such as a delivery catheter or similar.
In some such embodiments, the ventricle part is expandable from the delivery configuration to the deployed configuration by application of a radially outwards force to an inner surface thereof, for example, with a catheter-mounted balloon.
In some such embodiments, the ventricle part is self-expanding from the delivery configuration to the deployed configuration. Optionally, the annulus part and/or ventricle part are retractable, for example, by replacing the encasing sheath. Potentially, the valve position is adjustable.
Connecting of the Two Parts
As noted above, in some embodiments the annulus part and the ventricle part of the prosthetic mitral valve are two physically separate components.
In some embodiments, the annulus part and the ventricle part are configured for mutual fixation in the deployed configurations, that is to say, when each part is in a deployed configuration and the prosthetic mitral valve is deployed in a heart, the two parts can be fixed one to the other. Optionally or additionally, the two parts are approximated (e.g., to align the parts) and then attached to one another. In some embodiments, the configuration comprises the presence of eyelets, gaps, tabs or the like allowing mutual fixation, optionally with the help of an additional component, for example, a suture, attachment rings, ties and the like, for example, as will be described below.
In some embodiments, the annulus part and the ventricle part are mateable in the deployed configuration, that is to say, the annulus part includes one or more mating features configured to engage one or more mating features in the ventricle part. In some such embodiments, at least one of the annulus part and the ventricle part includes bending mating features, configured to be bent (in this context bent being an adjective, not a verb) when the annulus part and the ventricle part are mated (in this context, mated being an adjective not verb).
Tether
In some embodiments, the prosthetic mitral valve further comprises at least one elongated tether (e.g., a string, a filament, a thread, for example of non-dissolving suture material, polyethylene or PTFE) configured to assist in preventing the deployed prosthetic mitral valve from moving into the left atrium, for example, during systole.
In some embodiments, the prosthetic mitral valve further comprises at least one elongated tether having a distal end functionally associated with the annulus part (e.g., tied, glued, crimped thereto) and a proximal end configured for securing in proximity of the apex of a heart in which deployed, for example, sutured, tied to an anchor. Potentially, the tether maintains the position of the valve under pressure in the annulus part (e.g., when valve is closed during systole) directed from the ventricle to the atrium assisting in preventing the annulus part from moving into the left atrium. In some cases, a force applied to the proximal end of the tether is at least partially transferred by the annulus part to an atrial surface near the mitral valve annulus.
In some embodiments, the prosthetic mitral valve further comprises at least one elongated tether having a distal end functionally associated with the ventricle part (e.g., tied, glued, crimped thereto) and a proximal end configured for securing in proximity of the apex of a heart in which deployed (e.g., sutured, tied to an anchor), wherein a portion of the tether passes through the annulus part (e.g., loops through, slidingly associated with) so that tension (or other force) applied from the proximal end of the tether (e.g., by the securing to the apex) pulls the ventricle part towards the annulus part. Optionally, the force is at least partially transferred by the annulus part to an atrial surface near a native mitral valve annulus in which deployed. Potentially, the tether assists in preventing the annulus part from moving into the left atrium.
Optionally, the same tether is used to anchor the annulus part and the ventricle part. Alternatively, different tethers are used, for example, at least one tether to anchor the annulus part and at least one different tether to anchor the ventricle part.
Any suitable elongated tether may be used, for example, a string, a filament or a thread, for example of non-dissolving suture material, polyethylene or PTFE.
Optionally, the distal end of a tether is secured (for example, by tying or fastening) to the part of the prosthetic mitral valve to be functionally associated therewith.
Optionally, the distal end of a tether is configured for securing in proximity of the apex of a heart in which deployed by being securable to an anchor penetrating into the cardiac muscle (for example, as disclosed in PCT patent publication WO2007/135101) or by being configured to pass through the cardiac muscle to be secured to a pad that contacts the outer surface of the heart, e.g., such as pads commercially-available with the Coapsys® device from Myocor, Inc., Maple Grove, Minn., USA.
Delivery Device for a Prosthetic Mitral Valve
Embodiments of the prosthetic mitral valve disclosed herein may be deployed using any suitable method, including open-heart surgery and minimally-invasive surgery, for example with a deployment device such as a flexible catheter that enters the left ventricle through the vasculature and the aorta, with a deployment device such as a catheter that enters the left atrium through the roof of the left atrium or transeptallly from the right atrium, and/or transapically with a deployment device such as a transapical catheter that enters the left ventricle through the cardiac apex.
In an exemplary embodiment of the invention, the prosthetic mitral valve is transapically deployed using a deployment device, for example, as described herein.
According to an aspect of some embodiments of the invention there is provided a deployment device for transapically deploying a prosthetic mitral valve contained therein, comprising:
a) a substantially tubular delivery housing including a delivery lumen having an opening at a distal end thereof, the delivery housing configured for transapical entry into a mammalian heart the distal end first;
b) inside the delivery lumen, an annulus part of a prosthetic mitral valve (substantially as described above) defining a prosthetic mitral valve lumen and having a proximal portion, in a compact delivery configuration, the annulus part outwardly radially expandable, subsequent to release from the delivery housing, to a deployed configuration configured for deployment inside a left atrium of a heart in which deployed wherein the proximal portion passes into (and in some embodiments through) the mitral valve annulus of the heart;
c) inside the delivery lumen, proximally from the annulus part, a ventricle part of a prosthetic mitral valve (substantially as described above) physically separate from the annulus part, in a compact delivery configuration, the ventricle part outwardly radially expandable, subsequent to release from the delivery housing, to a deployed configuration configured for deployment in a left ventricle of a heart at least partially encircling the proximal portion of the annulus part;
d) an annulus-part release component (in some embodiments, activatable from a proximal end of the delivery housing) allowing release of the annulus part through the distal end of the delivery housing;
e) a ventricle-part release component (in some embodiments, activatable from a proximal end of the delivery housing) allowing release of the ventricle part through the distal end of the delivery housing; and
f) a joining component functionally associated with the annulus part and the ventricle part of the prosthetic mitral valve, the joining component configured to bring the annulus part and the ventricle part together when the annulus part is in the deployed configuration subsequent to release from the delivery housing, allowing deployment of the prosthetic mitral valve in a heart.
In some embodiments, the annulus part includes a valve mechanism functionally associated with the prosthetic mitral valve lumen, the valve mechanism suitable for functioning as a mitral valve.
Balloon-Expandable Annulus Part
In some embodiments, the deployment device further comprises an annulus-part expansion assembly, configured to apply a radially outwards force to an inner surface of the annulus part subsequent to release from the delivery housing to radially expand the annulus part from the delivery configuration to the deployed configuration, for example, the annulus-part expansion assembly includes a catheter-mounted balloon catheter.
In some such embodiments, the annulus part and the annulus-part expansion assembly are together configured so that in the deployed configuration, the annulus part conforms to an atrial contour near a native mitral valve in which deployed, for example, when the annulus-part expansion assembly is a catheter-mounted balloon, the balloon has an inflated shape similar to the atrial contour near the native mitral valve, and/or the balloon is a compliant balloon that adopts the shape of the atrial contour near the native mitral valve when inflated. Alternatively or additionally, the balloon is shaped according to the desired deployment shape of the annulus part, for example, having the funnel shape as previously described.
Self-Expanding Annulus Part
In some embodiments, the annulus part is self-expanding from the delivery configuration to the deployed configuration subsequent to release from the delivery housing. In some such embodiments, the annulus part is configured so that in the deployed configuration, the annulus part dynamically conforms to a mitral valve annulus and/or to atrial walls in proximity of the mitral valve of a heart in which deployed, as described above.
Balloon-Expandable Ventricle Part
In some embodiments, the deployment device further comprises a ventricle-part expansion assembly, configured to apply a radially outwards force to an inner surface of the ventricle part subsequent to release from the delivery housing to radially expand the ventricle part from the delivery configuration to the deployed configuration, for example, the ventricle-part expansion assembly includes a catheter-mounted balloon catheter.
Self-Expanding Ventricle Part
In some embodiments, the ventricle part is self-expanding from the delivery configuration to the deployed configuration subsequent to release from the delivery housing.
Tether
In some embodiments, the deployment device further comprises, inside the delivery lumen, at least one elongated tether of a prosthetic mitral valve (as described above), the at least one elongated tether having a distal end functionally associated with the annulus part of the prosthetic mitral valve and a proximal end configured for securing in proximity of the apex of a heart in which deployed, so that a force applied to the proximal end of the tether is at least partially transferred by the annulus part to an atrial surface near a native mitral valve annulus in which deployed.
In some embodiments, the deployment device further comprises, inside the delivery lumen, at least one elongated tether of a prosthetic mitral valve (as described above), the at least one elongated tether having a distal end functionally associated with the ventricle part of the prosthetic mitral valve and a proximal end configured for securing in proximity of the apex of a heart in which deployed, wherein a portion of the tether passes through the annulus part of the prosthetic mitral valve so that force applied to the proximal end of the tether pulls the ventricle part towards the annulus part, and is at least partially transferred by the annulus part to an atrial surface near a native mitral valve annulus in which deployed.
Annulus Part Placement Component
In some embodiments, the deployment device further comprises an annulus-part placement component functionally associated with the annulus part of the prosthetic mitral valve, configured to assist in properly positioning the annulus part in a native mitral valve annulus when in the deployed configuration. In some embodiments, the annulus-part placement component is functional to pull and/or push the annulus part proximally from the volume of the left ventricle (in which the annulus part was expanded to the deployed configuration) into the mitral valve annulus. In some embodiments, the annulus-part placement component is an elongated component, rigid (e.g., a rigid wire) or flexible (e.g., a filament, string or thread), having a distal functionally associated with (e.g., secured, temporarily or permanently) the annulus part and a proximal end that is accessible from the proximal end of the delivery housing, e.g. for pulling or pushing.
In some embodiments, the annulus-part placement component is configured to also function as a deployable tether, substantially as described above.
Mater Component
As discussed above, in some embodiments, the annulus part and the ventricle part are configured for mutual fixation in the deployed configurations.
In some such embodiments, the annulus part and the ventricle part are mateable in the deployed configurations. Optionally, the annulus part includes a first mating feature configured to engage a second mating feature in the ventricle part. Optionally, the deployment device further comprises a mater component, configured to assist in effecting the mating of the annulus part and the ventricle part. In some embodiments, the role of the mater is performed by a joining component, discussed below.
In some such embodiments, at least one of the annulus part and the ventricle part include a bending mating feature, configured to be bent when the annulus part and the ventricle part are mated (as discussed above). Optionally, the mater component is configured to bend the bending mating features. In some embodiments, the role of the mater is performed by a joining component, discussed below.
Joining Component
As noted above, in some embodiments, the deployment device comprises a joining component functionally associated with the annulus part of the prosthetic mitral valve and/or with the ventricle part of the prosthetic mitral valve, the joining component configured to bring the annulus part and the ventricle part together when the annulus part is in the deployed configuration. In an exemplary embodiment of the invention, the joining component is configured to perform one or more functions including:
    • to function as a ventricle-part release component, e.g., functional for removing (e.g., by pulling) the ventricle part out of the delivery housing through the distal opening of the delivery housing.
    • to function as an annulus-part placement component, e.g., functional for pulling the annulus component into a native mitral valve annulus, substantially as described above.
    • to function as a deployable tether, substantially as described above.
    • to function as a mater component, substantially as described above, for example, configured to bend mating features of at least one of the annulus part and the ventricle part, thereby mating the two parts.
In some embodiments, the joining component comprises at least one elongated flexible component that is slidingly associated with (e.g., loops around) a portion of the annulus part. Optionally, a proximal end is accessible from a proximal end of the delivery housing (e.g., for pulling), and a distal end secured to the ventricle part. Any suitable elongated flexible component may be used, for example, a string, a filament or a thread, for example of non-dissolving suture material, polyethylene or PTFE. Optionally, the distal end of the joining component is secured (for example, by tying or fastening) to the ventricle part.
In some such embodiments, the joining component is releasably secured to the ventricle part, for example, the joining component is released from the ventricle part after deployment. In some such embodiments, the joining component is fixedly secured (e.g., permanent) to the ventricle part, for example allowing the joining component to serve as a tether.
Parts of an embodiment of a prosthetic mitral valve as described herein, prostheticmitral valve50, are schematically depicted inFIGS. 2A and 2B, in accordance with an exemplary embodiment of the invention. InFIGS. 2A and 2B, anannulus part52 and aventricle part54 are depicted. Optionally,parts52 and54 are physically separate and distinct. Optionally,parts52 and/or54 are fashioned of self-expanding material, for example, nitinol. Optionally,parts52 and/or54 are biased to a larger outer radius deployed configuration. In one example,parts52 and/or54 are substantially self-expanding stents, laser-cut from a 10 mmouter diameter 1 mm thick tube of nitinol.
In an exemplary embodiment of the invention,annular portion52 comprises avalve mechanism350, for example, as described in the section “valve mechanism”.
InFIG. 2A,annulus part52 andventricle part54 are depicted in a compact delivery configuration, for example, as if held inside a delivery lumen of a delivery housing (e.g., of a deployment device such as a valve-deployment catheter), The length ofannulus part52 is, for example, about 20 mm long, or about 24 mm, or about 26 mm, or about 30 mm, or about 34 mm, or about 38 mm, or about 42 mm, or about 46 mm, or about 50 mm, or other smaller, intermediate or longer length. The length ofventricle part54 is, for example, about 6 mm long, or about 8 mm, or about 10 mm, or about 12 mm, or about 14 mm, or about 16 mm, or about 20 mm, or other smaller, intermediate or larger sizes.
Annulus part52 defines a prostheticmitral valve lumen66 that passes throughannulus part52 between aproximal end56 and adistal end60.
Optionally,annulus part52 is divided into two portions betweenproximal end56 anddistal end60, aproximal portion62 and adistal portion64. Optionally,distal portion64 is entirely defined by struts. Optionally or additionally, the distal part ofproximal portion62 is defined by struts while the proximal part is optionally defined by one or more attachment elements adapted to connect to the ventricle part. For example, 1, 3, 5, or other number of attachment elements. For example,perforated tabs58. The length oftabs58 is, for example, about 10 mm, about 7 mm, about 5 mm, or other smaller, intermediate or larger lengths. Optionally, the attachment elements are spread around the circumference, for example, about evenly around.
Amongst other functions,tabs58 constitute configuration ofannulus part52 for mutual fixation ofannulus part52 andventricle part54. Other not necessarily limiting examples of attachment elements include; eyelets, gaps, latches.
In some embodiments,attachment elements300 are adapted for directly grabbing or attachingannulus part52 toventricle part54. Optionally,elements300 are located onannulus part52. Alternatively or additionally,elements300 are located onventricle part54. Optionally,attachment elements300 are finger like extensions oriented so that whenventricle part54 is approximated withatrial part52, struts ofventricle part54 are positioned between the fingers ofattachment elements300. Optionally,elements300 are bendable, for example, by using a device such as a surgical clamp, fingers ofelements300 can be bent around struts ofventricle part54 to maintain the approximated position. Alternatively or additionally,elements300 are one way clasps, so that once struts ofventricle part54 enter the claps, the struts cannot leave.
In an exemplary embodiment of the invention, disposed insidelumen66 is a pericardialtrileaflet valve mechanism67. Optionally,valve67 is secured to the struts making up the distal part ofproximal portion62.
Ventricle part54 has adistal end68 and aproximal end70.
InFIG. 2B,annulus part52 andventricle part54 are depicted unconstrained and adopting a deployed configuration, in accordance with an exemplary embodiment of the invention.
In an exemplary embodiment of the invention, annulus portion (e.g., in the expanded state) has a funnel-like shape (e.g., having a narrower (axial dimension) proximal portion and a wider (axial dimension) distal portion). Alternatively, a cylindrical shape, or other shapes are used. An outer diameter atdistal end60 is, for example, about 30 mm, or about 34 mm, or about 38 mm, or about 42 mm, or about 48 mm, or about 52 mm, or other smaller, intermediate or larger diameters. The outer diameter atproximal end56 is, for example, about 19 mm, or about 23 mm, or about 27 mm, or about 31 mm, or about 35 mm, or other smaller, intermediate or larger sizes. The total length ofannulus part52 is, for example, about 20 mm, or about 24 mm, or about 28 mm, or about 32 mm, or other smaller, intermediate or larger lengths. Optionally, the length of proximal portion62 (comprising the replacement leaflets) is, for example, about 10 mm, or about 14 mm, or about 18 mm, or other smaller, intermediate or larger lengths. Optionally, the length ofportion62 includes an additional length of tabs58 (the tabs described below). Alternatively, the overall length already includes thetabs58. Alternatively, thetabs58 do not extend part end ofportion62, for example, incorporated therein.
In some embodiments, the size and/or shape ofannulus part52 is such thatannulus part52 is configured for deployment inside a left atrium of a heart whereinproximal portion62 passes into a mitral valve annulus andtabs58 extend into the left ventricle of the heart and at least partially beyond the native mitral valve leaflets, while the outer surface ofdistal portion64 snugly rests against the inner walls of the left atrium in proximity of the mitral valve annulus.
In an exemplary embodiment of the invention, the cross section ofventricle part54 is approximately trapezoidal, potentially the shape around the native leaflets. Alternatively, other shapes are used, for example, circles, ellipses. In some embodiments, theventricle part54 of the prosthetic mitral valve has a diameter larger than that of the native mitral valve orifice. Alternatively, the diameter is smaller than the native mitral valve orifice. The outer diameter atdistal end68 and/orproximal end70 is, for example, about 24 mm, about 28 mm, about 32 mm, or about 36 mm, or about 40 mm, or about 44 mm, or other smaller, intermediate or larger sizes. Optionally, the diameters ofends68 and70 are different, to create a tapered or cone-like configuration. The length of portion206 is, for example, about 6 mm, or about 10 mm, or about 14 mm, or other smaller, intermediate or larger sizes.
In an exemplary embodiment, the size and/or shape ofventricle part54 is such that whenannulus part52 is deployed inside a left atrium of a heart as described above,ventricle part54 can be placed over so as to encircleproximal portion62 ofannulus part52 and the native mitral valve leaflets of the heart.
In an exemplary embodiment of the invention, the valve is designed to fit within a wide range of mitral valve annulus diameters, for example, children, patients with dilated ventricles and/or atria, patients having undergone previous mitral valve surgery and/or cardiac reconstructive surgery.
As noted above, pericardialtrileaflet valve mechanism67 is disposed insidelumen66 and is secured to the struts making upproximal portion62 ofannulus part52, for example,valve67 is sewed, glued, crimped and/or dip-moulded ontoannulus part52.Valve mechanism67 is oriented in a direction so that whenannulus part52 is in a deployed configuration as depicted inFIG. 2B,valve mechanism67 is functional for allowing the flow of blood fromdistal end60 toproximal end56 throughlumen66. Optionally or additionally,valve67 is oriented for blocking the retrograde flow of blood fromproximal end56 todistal end60 throughlumen66. In such a way,valve mechanism67 is functionally associated withlumen66 in a manner suitable for functioning as a mitral valve.
In an exemplary embodiment of the invention, the diameter ofannulus portion52housing replacement valve67 is, for example, about 12 mm, about 14 mm, about 16 mm, about 18 mm, about 20 mm, about 22 mm, about 24 mm, about 26 mm, about 28 mm, about 30 mm, about 32 mm, about 34 mm, about 36 mm, about 38 mm, about 40 mm, or other smaller, intermediate or larger diameters. In some embodiments, a variety of sizes are available for different patient groups. Some not necessarily limiting examples of factors affecting the selection of the size include; age of patient (e.g., pediatric vs adult), mitral valve annulus size (e.g., normal vs dilated, native valve vs prosthetic valve or annuloplasty). Alternatively, only a small number of sizes are available, for example, one size is available for adults regardless of the mitral valve annulus size, as the amount of leaflets squeezed is varied to fit in the different annulus sizes. For example, in a patient with a larger annulus, less leaflet area is squeezed than in a patient with a smaller annulus.
In an exemplary embodiment of the invention, a height ofpart52 is long enough to attach tovalve67. Optionally or additionally, the height is long enough to provide anchoring against the leaflets. The height is, for example, at least 5 mm, or at least 7 mm, or at least 10 mm, or at least 15 mm, or at least 20 mm, or other smaller, intermediate or larger values are used.
In an exemplary embodiment of the invention,proximal portion62 of portion204 is long enough to pass into the ventricle when deployed in the mitral valve annulus, for example,tabs58 extend into the ventricle. Alternatively,portion62 does not extend past the annulus into the ventricle.
InFIG. 2B is also depicted one ormore filaments72 that are configured to act as a joining component to bringannulus part52 andventricle part54 together when in a deployed configuration. Optionally, the distal ends offilament72 are secured (e.g., by tying, gluing, crimping) to struts ofventricle part54. Optionally,filament72 loops around a portion of annulus part54 (e.g., through perforations intabs58, around and/or through struts). Operation offilament72 as a joining component is discussed in detail hereinbelow.
InFIG. 3, an embodiment of a deployment device,74, for deploying a prostheticmitral valve50 contained therein is schematically depicted in side cross section, in accordance with an exemplary embodiment of the invention.Device74 is designed for deployment of the valve by placement of the device in the left ventricle, for example, using a transapical approach, or a vascular approach via the aorta. Optionally,deployment device74 comprises a substantiallytubular delivery housing76. Optionally,device74 includes adelivery lumen78 having adistal opening80 at adistal end82 thereof. Optionally or additionally,device74 includes aproximal opening84 at aproximal end86 thereof. In some embodiments,Delivery housing76 is fashioned of biocompatible materials and in a manner known in the art to allow minimally invasive (e.g., transapical or percutaneous) entry into a human heartdistal end82 first.
In an exemplary embodiment,annulus part52 of prostheticmitral valve50 is held insidedelivery lumen78 in a compact delivery configuration, optionally, neardistal opening80.
Optionally, contacting the proximal ends (e.g., tabs58) ofannulus part52 is adistal end88 of anoptional push rod90. Optionally, pushrod90 extends proximally, exitingdelivery lumen78 fromproximal opening84 through an optional first passage in an optional sterility preservingsealing ring92. As is discussed below, pushrod90 constitutes an annulus-part release component that is optionally activatable fromproximal end86 ofdelivery housing76, for example, by slidingly pushingpush rod90 in a distal direction. Optionally, pushrod90 is manually activated, for example, by the operator. Alternatively, pushrod90 is automatically activated, for example, by a robot.
Optionally or additionally, aventricle part54 of prostheticmitral valve50 is held insidedelivery lumen78 in a compact delivery configuration, optionally, proximally todistal end88 ofpush rod90 and optionally surroundingpush rod90.
In some embodiments,annulus52 andventricle54 are physically separate and housed in one tube. Alternatively, two separate delivery tubes are used, onehousing annulus52 and onehousing ventricle54.
In some embodiments, the delivery device is sold pre-assembled and loaded with the selected prosthetic valve. Alternatively, the delivery device is assembled by the physician before the procedure, for example, the delivery device is standard, and the valve is variable. In such a case, the physician may fill the lumen with fluid (e.g., saline) before delivery.
In some embodiments, anoptional filament72 is also held insidedelivery lumen78. For clarity, and as noted above, details offilament72 will be discussed with reference toFIG. 2B.
Optionally, a proximal end94 (FIG. 3) offilament72 comprises a single strand, for example, made of flexible ultrahigh molecular weight polyethylene (UHMWPE). Optionally,proximal end94 offilament72 extends proximally, exitingdelivery lumen78 fromproximal opening84 through an optional second passage in optional sterility preservingsealing ring92.
Optionally, near a distal end96 (and as seen inFIG. 2B),filament72 comprises, for example, two, three, five or other number of (e.g., separate) strands (e.g., of UHMWPE) attached (e.g., tied, glued, crimped) to the proximal strand (e.g., single strand). Each one of the separate strands loops around a portion of annulus part52 (for example, through a perforation in a tab58) so that the separate strands can slidingly move therethrough. Optionally, one or more of the separate strands are secured (e.g. by tying, gluing, crimping) around an element (e.g., strut) and through a gap in the side ofventricle part54 so that the strands are distributed (e.g., equally) around the periphery ofventricle part54.
In some embodiments,filament72 andtabs58 together constitute parts of a ventricle-part release component. Optionally, the ventricle release component is activatable (e.g., by the user), for example, fromproximal end86 ofdelivery housing76. Optionally or additionally,filament72 andtabs58 constitute parts of a joining component configured to bringannulus part52 andventricle part54 together, for example, whenannulus part52 is in a deployed configuration, for example, subsequent to release fromdelivery housing76.
Optionally or additionally,filament72 andtabs58 constitute parts of an annulus-part placement component configured to assist in properly positioningannulus part52 in a native mitral valve annulus, for example, when in a deployed configuration. Optionally or additionally, the parts constitute parts of a deployable tether, for example, as described herein.
In some embodiments, the empty volume ofdelivery lumen78 is filled with a sterile preservative solution (e.g., glutaraldehyde solution) to maintain the valve mechanism of prostheticmitral valve50 sterile and ready for use.
Optionally, acap98 sealsdistal opening80, potentially preventing or reducing loss of the preservative solution and of sterile conditions insidedelivery lumen78.
Exemplary Deployment Method
FIG. 6 is a flowchart of a method for deploying a prosthetic mitral valve, using the deployment device, in accordance with an exemplary embodiment of the invention. Optionally, the trans-apical approach is used. However, the method is applicable to other approaches, for example, trans-vascular approaches through the aorta into the left ventricle. To help understand the method, reference will also be made toFIGS. 4A-4H which graphically illustrate the method as applicable to self expandingannulus part52 andventricle part54. To help understand the method, reference will also be made toFIGS. 5A-5G which illustrate the method as applicable toannulus part52 andventricle part54 that are expandable to application of an outward radial force.
In some embodiments, at least some of the procedure is performed under fluoroscopic guidance.
Optionally, at802 and/or at4A, access to the heart is obtained, for example, byapex48 puncture. Alternatively, access to the heart is obtained using a vascular approach, for example, obtaining access in the femoral artery, and threading a guidewire and/or catheter to the heart through the aorta, or from the femoral artery, into the right atrium, and after making a septal puncture to the left atrium. Optionally, a guide wire100 (e.g., soft and/or flexible) is passed retrograde across native mitral valve26 (e.g., regurgitant or other defects).
Optionally, at806,delivery device74 and/or106 is prepared. Optionally, cap98 ofdeployment device74 is removed. Optionally or additionally, the preservative solution is washed out ofdelivery lumen78. Optionally or additionally, the solution is replaced with saline while ensuring adequate degassing ofdelivery lumen78.
In some embodiments,deployment device74 is guided distal end first alongguide wire100 untildistal opening80 is located insideleft atrium24, for example, acrossmitral annulus34. Optionally,guide wire100 is withdrawn (FIG. 4B,FIG. 5A).
At808 and/orFIG. 4C, the annular component is deployed. Optionally, push rod90 (see back toFIG. 3) is pushed distally to function as an annulus-part release component. Optionally,rod90 pushes annuluspart52 out ofdelivery housing76, for example, throughdistal opening80, into the volume ofleft atrium24.
In some embodiments, once released from the confines ofdelivery housing76,annulus part52 self-expands to adopt a deployed configuration inside leftatrium24. In some embodiments,annulus part52 remains associated withdelivery housing76, for example, throughfilament72.
Alternatively in some embodiments, as shown inFIG. 5B, rigidballoon inflation tube108 is pushed forward to function as an annulus-part release component. Optionally,tube108 carriesannulus part52 crimped ondistal balloon110 out ofdelivery housing76 into the volume ofleft atrium24. Optionally or additionally,tube108 functions as a ventricle-part release component. Optionally,tube108 carriesventricle part54 crimped onproximal balloon112 out ofdelivery housing76 into the volume ofleft ventricle28.
In some embodiments, inflation fluid (e.g., saline) is forced through one lumen ofballoon inflation tube108, inflatingdistal balloon110 and thereby expandingannulus part52 insideleft atrium24. In such embodiments,distal balloon110 functions as a component of an annulus-part expansion assembly. Optionally, the inflation fluid is withdrawn, deflating distal balloon110 (FIG. 5C).
In some embodiments, theannulus part52 comprises one or more piercing elements adapted to pierce the leaflets, for example, upon expansion ofannulus part52. Alternatively or additionally, the piercing elements are adapted to pierce surrounding tissues, for example, the fibrous ring and/or the atrium wall. Not necessarily limiting examples of piercing elements include; barbs, hooks, needles. Potentially, the piercing elements help anchorannulus part52 to the leaflets and/or surrounding tissues.
At810 and/orFIG. 4D, the annular component is approximated with the native mitral valve annulus.
In some embodiments,deployment device74 is withdrawn in a proximal direction so thatdistal opening80 is located insideleft ventricle28.
Optionally,proximal end94 offilament72 is pulled proximally so thatfilament72 functions as an annulus-part placement component, pullingannulus part52 to a properly deployed position inmitral valve annulus34.
Optionally,proximal portion62 ofannulus part54 is directed intomitral valve annulus34. Optionally or additionally, a portion thereof (e.g., tabs58) passes throughmitral valve annulus34, intoleft ventricle28, and optionally past the edges ofmitral valve leaflets38 and40. Alternatively, in some embodiments as shown inFIG. 5D, proximal end offilament72 is pulled proximally through the proximal end ofdelivery housing76 whileballoon inflation tube108 is held in place. In such embodiments,filament72 functions as the annulus-part placement component, pullingannulus part52 to a properly deployed position inmitral valve annulus34.
Optionally at812, the position ofannulus part52 inmitral valve annulus34 is confirmed, for example, by imaging (e.g., fluoroscopy, ultrasound).
Optionally, at804, the chordae are disconnected from papillary muscles (both not depicted inFIG. 4 for clarity), for example by cutting with a tool that is guided alongguide wire100 or is inserted through the apex incision, such as a knife.
In practice, once the annular component has been deployed, leaflets will remain in the ventricle even if cords are removed, as the leaflets will be held in position by the annular part against the mitral valve annulus, being prevented from prolapsing back into the atrium by the annular component. Alternatively, some of the cords are disconnected and some are left intact, for example, if using the ventricle component that is a partial ring.
Alternatively, in some embodiments, the chords are not cut. Optionally, the embodiment of the partial-circumference ventricle component is used.
At814 and/orFIG. 4E, the ventricular component is deployed. Optionally, filament72 (e.g.,proximal end94 thereof) is pulled proximally to function as a ventricular-part release component. Optionally,filament72 pullsventricle part54 out ofdelivery housing76, for example, throughdistal opening80 into the volume ofleft ventricle28.
In some embodiments, once released from the confines ofdelivery housing76,ventricle part54 self-expands to adopt a deployed configuration insideleft ventricle28.
Alternatively, in some embodiments and as illustrated inFIG. 5E, inflation fluid is forced through the second lumen ofballoon inflation tube108, inflatingproximal balloon112 and thereby expandingventricle part54 insideleft ventricle28. In such embodiments,proximal balloon112 functions as a component of the ventricle-part expansion assembly. Optionally, the inflation fluid is withdrawn, deflatingproximal balloon112.
At816 and/orFIG. 4F orFIG. 5F, the annular and ventricle portions are approximated.
Optionally in some embodiments, the approximation is performed by an approximating and/or joining component. Optionally,proximal end94 offilament72 is pulled proximally even further than inbox814. Optionally,filament72 functions as an approximating component,positioning annulus part52 andventricle part54 in close proximity. Optionally or additionally,filament72 functions as a joining component, pullingventricle part54 over at least a portion ofmitral valve leaflets38 and/or40 and/or overproximal portion62 ofannulus part52. Optionally or additionally,ventricle part54 at least partially encircles portions ofproximal portion62 ofannulus part52, (e.g., tabs58) as well asmitral valve leaflets38 and/or40.
In some embodiments, one filament branches out into multiple attachment locations onannulus52. Potentially, pulling on the one filament moves and/or approximatesannulus52 withventricle54. Alternatively, each attachment location is associated with an independent filament, and each filament requires pulling. Potentially, the multiple filaments allow increased control over the approximation, as pulling the different filaments associated with locations aroundannulus52 can tilt the valve, or move the valve in a radial direction.
In some embodiments, the pulling anchors the prosthetic valve toleaflets38 and/or40 betweenventricle part54 and annulus part52 (e.g., proximal portion62).
Alternatively, in some embodiment, the approximation is performed by using one or more balloons (note that the balloons can be used even in embodiments in which ventriclepart54 and/orannulus part52 are self expanding). Optionally, a first balloon is expanded inside the expanded annulspart52. In the embodiment in which annuluspart52 is funnel shaped, the first balloon prevents distal movement ofannulus part52 into the left ventricle. Optionally or additionally, a second balloon is expanded inside the expandedventricle part54. Optionally, the second balloon is wider proximally, wider than the diameter ofventricle part54, to prevent distal movement ofventricle part54 into the left ventricle. Optionally, the expanded balloons are used to guide and/or move theannulus part52 and/orventricle part54. For example, the operator can proximally pull the first balloon and distally push the second balloon, thereby approximatingannulus part52 andventricle part54.
Optionally, at822,filaments72 are tied together, in accordance with some embodiments of the invention. Optionally,filament72 is prearranged for easy tying, for example, having a pre-existing knot that requires tightening to secure the tying.
Optionally, at818 and/orFIG. 4G, the relative positions ofatrial part52 andventricle part54 are set so that relative movement is reduced and/or prevented.
In some embodiments,ventricle part54 comprises one or more piercing elements adapted to pierce the leaflets. Optionally or additionally, the piercing elements are adapted to pierce surrounding tissues, for example, the fibrous ring and/or ventricle wall. Optionally, the piercing occurs upon movingventricle part54 towardsatrial part52. Potentially the piercing elements help to grab on to the leaflets, and help to set the relative positions ofatrial part52 andventricle part54.
Optionally,balloon inflation tube108 is withdrawn fromdelivery housing76 in a proximal direction.
Optionally, a crimping tool102 (e.g., surgical clamp) and/or video camera103 (e.g., fiber-optic) are advanced intodelivery lumen78, for example, through suitable ports in sealingring92 ofdeployment device76, and/or through a different access route (e.g., through the vasculature using trans-catheter techniques). Optionally, crimpingtool102 is advanced to proximity withventricle part54, for example, throughdelivery lumen78 ofdelivery housing76. Optionally, tool102 (e.g., under guidance of a fiber-optic video camera103 and/or echo and/or fluoroscopy) is used to crimp connectors105 (e.g., 1, 3, 5, or other numbers) around the distal ends of filament72 (e.g., 1, 3, 5, or other numbers) (e.g., near the inner face of tabs58). Optionally, the crimping fixes the relative positions betweenannulus part52 andventricle part54. Alternatively or additionally,tool102 is used to crimpattachment elements300, for example, by bending the fingers ofelements300 so that the edges of the fingers overlap one another and ‘grab’ the struts ofventricle part54.
Optionally crimpingtool102 and/orvideo camera103 are withdrawn from the delivery lumen ofdelivery housing76.
Optionally, a cutting tool is inserted and is used to clip the distal ends offilament72, for example, close to crimpedconnectors105. Optionally, the cutting tool and the thus-released portion offilament72 are withdrawn fromleft ventricle28 in a proximal direction. Alternatively,filament72 remains secured to deployed prostheticmitral valve104. Optionally,proximal end94 trails out ofheart10 through the incision inapex48. Optionally, the incision is closed in the usual way.
In some embodiments,filament72 remains secured to deployed prostheticmitral valve104 withproximal end94 trailing out ofheart10 through the incision inapex48. Optionally,proximal end94 offilament72 is secured, for example, to apad114 that contactsouter surface116 ofheart10, for example, commercially-available pads with the Coapsys® device from Myocor, Inc., Maple Grove, Minn., USA. In some embodiments,filament72 functions as a tether, assisting in preventing prostheticmitral valve104 from moving intoleft atrium24, (FIG. 5G).
Optionally, at820 and/orFIG. 8H, the procedure is ended. Optionally,delivery housing76 is withdrawn fromheart10.
In some embodiments, prostheticmitral valve50 is deployed inheart10, surrounding nativemitral valve annulus34, grabbing at least some ofleaflets38 and/or40 from above withannulus part52 and from below withventricle part54.
Once the operation is complete, deployed prostheticmitral valve50 functions as a patent mitral valve. Potentially, the self-expanding properties ofannulus part52 and/orventricle part54 allow dynamic conformation to the shape and/or size ofmitral valve annulus34 and/or the atrial walls as these change during the beating ofheart10, potentially allowingparts52 and/or54 to adopt a smaller configuration whenmitral valve annulus34 compresses and/or to spring back to a larger-sized configuration whenmitral valve annulus34 relaxes.
In the embodiment discussed above with reference toFIGS. 3 and 4,annulus part52 andventricle part54 are self-expanding from a delivery configuration to a deployed configuration. In some embodiments, one or both of an annulus part and a ventricle part of a prosthetic mitral valve as described herein are expandable from a delivery configuration to a deployed configuration by application of a radially outward force applied to an inner surface thereof. In a not necessarily limiting example, the radially expandable portions are made for example, from steel 316L. Specifically, in some embodiments, an annulus part is self-expanding and a ventricle part is expandable by application of an outwards radial force. In a not necessarily limiting example, the radially expandable portion is made for example from steel, and the self expanding portion is made for example from Nitinol, with the portions attached together, for example, by welding, gluing, crimping or other methods. Alternatively, a ventricle part is self-expanding and an annulus part is expandable by application of an outwards radial force. Alternatively, both an annulus part and a ventricle part are expandable by application of an outwards radial force. Alternatively, annulus and/or ventricle parts are not expandable, for example, for surgical implantation. In such a case, other materials can be used, for example, polyurethane.
In some embodiments, the method ofFIG. 6 is used to deliver the radially expandable embodiments ofannulus part52 andventricle part54. InFIGS. 5A-5G are depicted the deployment of a prosthetic mitral valve as described herein, prostheticmitral valve104, that is substantially similar to prostheticmitral valve50 described above except that both anannulus part52 and aventricle part54 are expandable by application of an outwards radial force. In some embodiments, deployment is performed using an embodiment of a deployment device as described herein,deployment device106,
Optionally, at802, deployment begins as described above for prostheticmitral valve50. Optionally,deployment device106 is advanced so thatdistal opening80 is located inleft ventricle28 acrossmitral valve annulus34,FIG. 5A.
At808, (e.g., rigid)balloon inflation tube108 is pushed forward to function as an annulus-part release component. Optionally,tube108 carries annulus part52 (e.g., crimped on distal balloon110) out ofdelivery housing76 into the volume ofleft atrium24.
At810, a proximal end offilament72 is pulled proximally (e.g., through the proximal end of delivery housing76) whileballoon inflation tube108 is held in place. Optionally,filament72 functions as an annulus-part placement component, by pullingannulus part52 to a properly deployed position inmitral valve annulus34,FIG. 5D.
At814,tube108 also functions as a ventricle-part release component, carrying ventricle part54 (e.g., crimped on proximal balloon112) out ofdelivery housing76 into the volume ofleft ventricle28,FIG. 5B.
At816, a proximal end offilament72 is pulled proximally (e.g., through the proximal end of delivery housing76) whiledelivery housing76 is held in place. Optionally,filament72 functions as a joining component, bringingannulus part52 andventricle part54 together, by pullingventricle part54 overmitral valve leaflets38,40 and/or the proximal portion ofannulus part52,FIG. 5F.
At818, optionallyballoon inflation tube108 is withdrawn fromdelivery housing76 in a proximal direction. Optionally, a crimping tool is used to crimp connectors (e.g., three) around the distal ends of filament72 (e.g., three) near the inner face oftabs58. The crimping mutually fixingannulus part52 andventricle part54.
At820,optionally delivery housing76 is withdrawn fromheart10.
In some of the embodiment of the method described above, a crimpingtool102 and/or avideo camera103 were advanced throughdelivery lumen78 ofdeployment device74 to assist in deploying a prosthetic mitral valve. Alternatively, one or more of crimping tools, video cameras, and/or other devices for assisting in deploying a prosthetic mitral vale as described herein are brought to a desired location through a different access routes, for example, through the vasculature and into the heart through the aorta, for example, using a suitable catheter.
In some of the embodiments described above, a prosthetic mitral valve includes a valve mechanism that is not subject to prolapse of leaflets into the left atrium, whether due to the particular construction of the valve mechanism or due to the presence of a prolapse-preventing component. In some, non-depicted, embodiments, a prosthetic mitral valve as described herein includes a prolapse-preventing component that is substantially an artificial chorda, for example as described in WO 2009/134701. In some such embodiments, the artificial chordae are deployed substantially as described for a tether (in some embodiments instead of a tether, in some embodiments together with a tether), with the required differences as are clear to a person skilled in the art. Specifically, in such embodiments, the device further comprises a leaflet-valve mechanism functionally associated with the annulus part and at least one artificial chorda having a distal chorda end and a proximal chorda end, the distal chorda end secured to a portion (typically an edge) of at least one leaflet of the leaflet-valve mechanism and the proximal chorda end configured for securing in proximity of the apex of a heart in which deployed, for example, secured to an anchor engaging heart muscle tissue, or passing through the heart muscle and being anchored in place with a pad that presses against an outer wall of the heart. The chorda is configured (including the length thereof) so that motion of the leaflet edge towards the left ventricle is substantially uninhibited, but that prolapse of the leaflet edge into the left atrium is substantially prevented.
In some of the embodiments described above, the ventricle part of a prosthetic mitral valve is configured to at least partially encircle native mitral valve leaflets and is deployed at least partially encircling the native mitral valve leaflets. In some embodiments, the ventricle part of a prosthetic mitral valve is not necessarily configured to encircle native mitral valve leaflets and/or is not deployed at least partially encircling the native mitral valve leaflets. In some such embodiments, when deployed the ventricle part of such an embodiment of a prosthetic mitral valve encircles the proximal portion of the annulus part and. of necessary, is fixed thereto. By virtue of having a larger diameter than the diameter of the mitral valve annulus (especially during atrial systole), such a ventricle part cannot pass through the mitral valve annulus and thereby prevents the prosthetic mitral valve from moving into the left atrium, especially because the mitral valve annulus constricts during ventricular systole when there is the greatest possibility of such movement.
In the embodiments described above, the teachings herein are implemented to provide a prosthetic heart valve that is a prosthetic mitral valve, having features rendering the prosthetic heart valve exceptionally useful for overcoming challenges in the field of prosthetic mitral valve deployment. In some, non-depicted, embodiments, the teachings herein are implemented, with the required changes, to provided a prosthetic heart valve that is a prosthetic aortic valve.
In some embodiments, at least one of the annulus part and the ventricle part of a prosthetic mitral valve as described herein includes bending mating features, configured to be bent (in this context bent being an adjective, not a verb) when the annulus part and the ventricle part are mated (in this context, mated being an adjective not verb). For example, in some embodiments similar tovalves50 and104, the three distal ends offilament72 passes through gaps such as slots in the structure ofventricle part52 and are secured to bendable tabs (integrally formed or connected) that can pass into the gaps in annulus part. In such an embodiment, the gaps and the bendable tabs are mating features. When the proximal end offilament72 is pulled to joinannulus part52 andventricle part54, the bendable tabs are pulled to pass into the gaps, so that the two parts are mated. With further pulling of the proximal end offilament72, the bendable tabs are bent downwards, lockingannulus part52 andventricle part54 together. Subsequently,filament72 can be cut as described with reference to prostheticmitral valve50 or anchored to function as a tether as described with reference to prostheticmitral valve104.
Any suitable combination of materials and methods of manufacture may be used in implementing the teachings herein. For example, a person having ordinary skill in the art of prosthetic cardiac valves is able to select suitable materials and methods of manufacture, for example, with reference to commercially-available prosthetic cardiac valves.
The dimensions of the various parts and components of the prosthetic mitral valves and the deployment devices as described herein are any suitable dimensions, and can be determined by a person having ordinary skill in the art, for example, with reference to commercially-available transapical delivery devices and accompanying prosthetic cardiac valves, especially prosthetic mitral valves, for example the Perimount™ Magna prosthetic mitral heart valve by Edwards Lifesciences LLC (Irvine, Calif., USA).
Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the scope of the appended claims.
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.
Citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the invention.
Section headings are used herein to ease understanding of the specification and should not be construed as necessarily limiting.

Claims (30)

What is claimed is:
1. A method of deploying an expandable prosthetic mitral valve device in a subject, said method comprising:
deploying a first component of said prosthetic mitral valve device in a left atrium, the first component including an annulus part;
deploying a second component of said prosthetic mitral valve in a left ventricle, the second component including a ventricle part; and
approximating said first and said second components so that one or more leaflets of a native mitral valve are trapped between said first and said second components,
the method being performed using apparatus comprising:
the prosthetic mitral valve device for fitted insertion to a native mitral valve annulus of a heart of the subject, the prosthetic mitral valve comprising the annulus part and the ventricle part; and
a deployment device for deployment of the prosthetic mitral valve device, the deployment device comprising:
a delivery housing configured to house the annulus part and the ventricle part of the prosthetic mitral valve device in radially-compact configurations, wherein:
the annulus part and the ventricle part are each configured to be radially expandable subsequent to release from the delivery housing, and
the expanded ventricle part and the expanded annulus part are shaped to mate in a deployed mating configuration, such that there is a gap between the ventricle part and the annulus part, the gap being configured to accommodate one or more leaflets of the native mitral valve; and
an approximator that is configured, while attached to both the annulus part and the ventricle part:
to force each of the annulus part and the ventricle part toward the other from initially separated positions into the mating configuration, such that the one or more leaflets of the native mitral valve are held within the gap between the ventricle part and the annulus part; and
to secure the annulus part and the ventricle part in the mating configuration.
2. A method according toclaim 1, wherein said approximating comprises approximating by pulling a wire connecting said first and second elements.
3. A method according toclaim 1, further comprising joining said first and second elements to maintain an approximated position.
4. A method according toclaim 1, wherein said approximating comprises tightly trapping said native mitral valve leaflets.
5. A method according toclaim 1, further comprising piercing said leaflets by at least one of said first or said second components.
6. A method according toclaim 1, further comprising piercing tissues surrounding said leaflets by at least one of said first or said second components.
7. A valve deployment system comprising:
a prosthetic mitral valve device for fitted insertion to a native mitral valve annulus of a heart, the prosthetic mitral valve comprising an annulus part and a ventricle part; and
a deployment device for deployment of the prosthetic mitral valve device, the deployment device comprising:
a delivery housing configured to house the annulus part and the ventricle part of the prosthetic mitral valve device in radially-compact configurations, wherein:
the annulus part and the ventricle part are each configured to be radially expandable subsequent to release from the delivery housing, and
the expanded ventricle part and the expanded annulus part are shaped to mate in a deployed mating configuration, such that there is a gap between the ventricle part and the annulus part, the gap being configured to accommodate one or more leaflets of the native mitral valve; and
an approximator that is configured, while attached to both the annulus part and the ventricle part:
to force each of the annulus part and the ventricle part toward the other from initially separated positions into the mating configuration, such that the one or more leaflets of the native mitral valve are held within the gap between the ventricle part and the annulus part; and
to secure the annulus part and the ventricle part in the mating configuration.
8. The valve deployment system ofclaim 7, wherein said annulus part includes a valve mechanism suitable for functioning as a prosthetic mitral valve.
9. The valve deployment system ofclaim 7, further comprising an annulus-part expansion assembly, configured to apply a radially outwards force to an inner surface of said annulus part subsequent to release from said delivery housing to radially expand said annulus part from the radially-compact configuration.
10. The valve deployment system ofclaim 9, wherein said annulus part and said annulus-part expansion assembly are together configured so that said expanded annulus part conforms to an atrial contour near a native mitral valve of said mitral valve annulus.
11. The valve deployment system ofclaim 7, wherein said annulus part is self-expanding from the radially-compact configuration subsequent to release from said delivery housing.
12. The valve deployment system ofclaim 11, wherein said expanded annulus part is configured to dynamically conform to an atrial contour near a native mitral valve of said mitral valve annulus.
13. The valve deployment system ofclaim 7, further comprising a ventricle-part expansion assembly, configured to apply a radially outwards force to an inner surface of said ventricle part subsequent to release from said delivery housing to radially expand said ventricle part from the radially-compact configuration.
14. The valve deployment system ofclaim 7, wherein said ventricle part is self-expanding from the radially-compact configuration subsequent to release from said delivery housing.
15. The valve deployment system ofclaim 7, wherein the approximator comprises at least one elongated tether having a distal end functionally associated with said annulus part and a proximal end configured for securing in proximity of an apex of said heart, so that a force applied to said proximal end of said tether is at least partially transferred by said annulus part to an atrial surface near said native mitral valve annulus.
16. The valve deployment system ofclaim 7, wherein the approximator comprises at least one elongated tether having a distal end functionally associated with said ventricle part and a proximal end configured for securing in proximity of an apex of said heart, wherein a portion of said tether passes through said annulus part so that force applied to said proximal end of said tether pulls said ventricle part towards said annulus part, and is at least partially transferred by said annulus part to an atrial surface near said native mitral valve annulus.
17. The valve deployment system ofclaim 7, further comprising an annulus-part placement component functionally associated with said annulus part, configured to assist in properly positioning said annulus part in said native mitral valve annulus.
18. The valve deployment system ofclaim 17, said annulus-part placement component being configured to also function as a deployable tether.
19. The valve deployment system ofclaim 7, wherein at least one of said annulus part and said ventricle part include bending mating features, configured to be bent when said annulus part and said ventricle part are mated, and wherein said approximator is configured to bend said bending mating features.
20. The valve deployment system ofclaim 7, wherein said approximator is further configured to function as a ventricle-part release component.
21. The valve deployment system ofclaim 7, wherein said approximator is further configured to function as an annulus-part placement component.
22. The valve deployment system ofclaim 7, wherein said approximator is further configured to function as a deployable tether.
23. The valve deployment system ofclaim 7, wherein:
the expanded ventricle part and the expanded annulus part are shaped to mate in the deployed mating configuration, such that the ventricle part radially encircles the annulus part around a circumference of the annulus part surrounding and defining an annulus; and
said radial encircling is at a position at which the annulus part and the ventricle part are configured to hold the one or more leaflets of said native mitral valve annulus within the gap between said ventricle part and said annulus part when the valve is deployed with the annulus and ventricle parts in the mating configuration.
24. The valve deployment system ofclaim 7, wherein the expanded annulus part and the expanded ventricle part each narrow from wider to narrower between their respective distal and proximal portions, the proximal portions being configured to be positioned further in a direction toward the ventricle in the deployed configurations of the annulus and ventricle parts, and the ventricle part is configured to radially encircle the proximal portion of said annulus part in the deployed configurations of the annulus and ventricle parts.
25. The valve deployment system ofclaim 7, wherein the approximator operates to pull the ventricle part toward the annulus part to a position on a ventricular side of the prosthetic mitral valve, such that the ventricle part, at said position, is configured to at least partially encircle both a proximal portion of the annulus part and the one or more leaflets of the native mitral valve.
26. The valve deployment system ofclaim 7, wherein the deployment device is operable to deploy the prosthetic mitral valve device using at least one of a transapical approach, or a vascular approach.
27. The valve deployment system ofclaim 7, wherein the deployment device is operable to deploy the prosthetic mitral valve via a transseptal approach.
28. The valve deployment system ofclaim 7, wherein the approximator comprises a plurality of filaments each of which extends from the deployment device at one filament end to another filament end that is secured to the ventricle part, each of the filaments contacting a region of slidable association with the annulus part between the filament ends.
29. The valve deployment system ofclaim 28, wherein said approximator is configured to be releasably secured to said ventricle part.
30. The valve deployment system ofclaim 28, wherein said approximator is configured to be fixedly secured to said ventricle part.
US13/475,9942011-05-202012-05-20Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valveActiveUS10500038B1 (en)

Priority Applications (4)

Application NumberPriority DateFiling DateTitle
US13/475,994US10500038B1 (en)2011-05-202012-05-20Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valve
US16/655,656US11583394B2 (en)2011-05-202019-10-17Methods for deploying a prosthetic mitral valve
US18/103,671US12208003B2 (en)2011-05-202023-01-31Prosthetic mitral valve
US18/999,207US20250120805A1 (en)2011-05-202024-12-23Prosthetic mitral valve

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US201161488180P2011-05-202011-05-20
US13/475,994US10500038B1 (en)2011-05-202012-05-20Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valve

Related Child Applications (1)

Application NumberTitlePriority DateFiling Date
US16/655,656DivisionUS11583394B2 (en)2011-05-202019-10-17Methods for deploying a prosthetic mitral valve

Publications (1)

Publication NumberPublication Date
US10500038B1true US10500038B1 (en)2019-12-10

Family

ID=68766157

Family Applications (4)

Application NumberTitlePriority DateFiling Date
US13/475,994ActiveUS10500038B1 (en)2011-05-202012-05-20Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valve
US16/655,656Active2034-03-25US11583394B2 (en)2011-05-202019-10-17Methods for deploying a prosthetic mitral valve
US18/103,671ActiveUS12208003B2 (en)2011-05-202023-01-31Prosthetic mitral valve
US18/999,207PendingUS20250120805A1 (en)2011-05-202024-12-23Prosthetic mitral valve

Family Applications After (3)

Application NumberTitlePriority DateFiling Date
US16/655,656Active2034-03-25US11583394B2 (en)2011-05-202019-10-17Methods for deploying a prosthetic mitral valve
US18/103,671ActiveUS12208003B2 (en)2011-05-202023-01-31Prosthetic mitral valve
US18/999,207PendingUS20250120805A1 (en)2011-05-202024-12-23Prosthetic mitral valve

Country Status (1)

CountryLink
US (4)US10500038B1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN111067667A (en)*2019-12-272020-04-28先健科技(深圳)有限公司 Force measuring device and its push assembly
US10888644B2 (en)2019-02-062021-01-12inQB8 Medical Technologies, LLCIntra-cardiac left atrial and dual support systems
US10966824B2 (en)2015-11-062021-04-06Micor LimitedMitral valve prosthesis delivery system
US11020226B2 (en)2018-01-072021-06-01Jc Medical, Inc.Prosthetic heart valve delivery system
US20210205073A1 (en)*2020-01-082021-07-08Cephea Valve Technologies, Inc.Multi-component Valve Implant and Delivery Methods
US11259923B2 (en)*2013-03-142022-03-01Jc Medical, Inc.Methods and devices for delivery of a prosthetic valve
US11331187B2 (en)*2016-06-172022-05-17Cephea Valve Technologies, Inc.Cardiac valve delivery devices and systems
US11406497B2 (en)2013-03-142022-08-09Jc Medical, Inc.Heart valve prosthesis
US11439492B2 (en)*2016-09-072022-09-13Daniel Ezra WalzmanLasso filter tipped microcatheter for simultaneous rotating separator, irrigator for thrombectomy and method for use
CN115399917A (en)*2021-11-052022-11-29瀚芯医疗科技(深圳)有限公司Artificial chordae tendineae implanting device
US11666444B2 (en)2017-08-032023-06-06The Regents Of The University Of CaliforniaAtrial cage for placement, securing and anchoring of atrioventricular valves
US11779459B2 (en)2012-05-202023-10-10Tel Hashomer Medical Research Infra And Svcs LtdFrame for prosthetic valve
US20230320847A1 (en)*2008-05-012023-10-12Edwards Lifesciences CorporationProsthetic heart valve assembly
US11877752B2 (en)2016-09-072024-01-23Daniel Ezra WalzmanFilterless aspiration, irrigating, macerating, rotating microcatheter and method of use
US12036115B2 (en)2019-08-142024-07-16Innovalve Bio Medical Ltd.Atrioventricular valve replacement
US12138149B2 (en)2016-09-072024-11-12Daniel Ezra WalzmanEndovascular devices and methods with filtering elements
US12208003B2 (en)2011-05-202025-01-28Sheba Impact Ltd.Prosthetic mitral valve
US12350156B2 (en)2018-11-142025-07-08Sheba Impact Ltd.Atrioventricular valve repair
US12369932B2 (en)2016-09-072025-07-29Daniel Ezra WalzmanMethods and devices to ameliorate vascular obstruction

Citations (32)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2000060995A2 (en)1999-04-092000-10-19Evalve, Inc.Methods and apparatus for cardiac valve repair
US20020065554A1 (en)2000-10-252002-05-30Streeter Richard B.Mitral shield
US20030014104A1 (en)*1996-12-312003-01-16Alain CribierValue prosthesis for implantation in body channels
US20040138745A1 (en)2001-10-012004-07-15Ample Medical, Inc.Methods and devices for heart valve treatments
WO2005087140A1 (en)2004-03-112005-09-22Percutaneous Cardiovascular Solutions Pty LimitedPercutaneous heart valve prosthesis
US7018408B2 (en)*1999-12-312006-03-28Abps Venture One, Ltd.Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US20070016288A1 (en)*2005-07-132007-01-18Gurskis Donnell WTwo-piece percutaneous prosthetic heart valves and methods for making and using them
US20070050020A1 (en)2000-02-022007-03-01Spence Paul AHeart valve repair apparatus and methods
WO2007135101A1 (en)2006-05-182007-11-29Edwards Lifesciences AgDevice and method for improving heart valve function
DE102006052564B3 (en)2006-11-062007-12-13Georg LutterMitral valve stent for surgical implantation and fixation of heart valve prosthesis to heart, has stent clips arranged distally, where one of stent clips forms section that is externally rolled in unfolded condition of stent
US20080039935A1 (en)2006-08-142008-02-14Wally BuchMethods and apparatus for mitral valve repair
CN101180010A (en)2005-05-242008-05-14爱德华兹生命科学公司 rapid deployment prosthetic heart valve
US20090192586A1 (en)2008-01-242009-07-30Medtronic, Inc.Delivery Systems for Prosthetic Heart Valves
US20090192585A1 (en)2008-01-242009-07-30Medtronic, Inc.Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
WO2009134701A2 (en)2008-05-012009-11-05Edwards Lifesciences CorporationDevice and method for replacing mitral valve
US7621948B2 (en)2003-07-212009-11-24The Trustees Of The University Of PennsylvaniaPercutaneous heart valve
US20100022640A1 (en)2006-12-202010-01-28Donald Wesley StoutamireEsters of 2-phenylalkanenitriles and antifungal compositions containing them
US20100049313A1 (en)2008-08-222010-02-25Edwards Lifesciences CorporationProsthetic heart valve and delivery apparatus
US7753949B2 (en)2007-02-232010-07-13The Trustees Of The University Of PennsylvaniaValve prosthesis systems and methods
WO2010108079A1 (en)2009-03-192010-09-23Millipede LlcReconfiguring heart features
US20100249923A1 (en)2007-09-282010-09-30St Jude Medical Inc.Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features
US20110137397A1 (en)2009-12-042011-06-09Edwards Lifesciences CorporationProsthetic valve for replacing mitral valve
US20110137410A1 (en)2009-12-082011-06-09Hacohen GilFoldable hinged prosthetic heart valve
US20110264208A1 (en)2010-04-272011-10-27Medtronic, Inc.Prosthetic Heart Valve Devices and Methods of Valve Repair
US8070802B2 (en)2007-02-232011-12-06The Trustees Of The University Of PennsylvaniaMitral valve system
CN102292053A (en)2008-09-292011-12-21卡迪尔克阀门技术公司Heart valve
US20120010461A1 (en)2004-09-272012-01-12Abbott Vascular Inc.Methods and devices for tissue grasping and assessment
US20120022640A1 (en)2010-07-212012-01-26Yossi GrossTechniques for percutaneous mitral valve replacement and sealing
US20120101571A1 (en)2008-11-212012-04-26Percutaneous Cardiovascular Solutions Pty LimitedHeart valve prosthesis and method
WO2012095116A1 (en)2011-01-112012-07-19Hans Reiner FigullaValve prosthesis for replacing an atrioventricular valve of the heart
JP2012521222A (en)2009-03-192012-09-13ミリピード リミテッド ライアビリティー カンパニー Reconstruction of cardiac features
WO2013175468A2 (en)2012-05-202013-11-28Tel Hashomer Medical Research Infrastructure And Services Ltd.Prosthetic mitral valve

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6270520B1 (en)1995-05-192001-08-07Kanji InoueAppliance to be implanted, method of collapsing the appliance to be implanted and method of using the appliance to be implanted
WO2006116558A2 (en)1999-04-092006-11-02Evalve, Inc.Device and methods for endoscopic annuloplasty
DE10021096A1 (en)2000-04-202001-10-31Infineon Technologies Ag Mask for projection optical systems and a method for their production
ATE402670T1 (en)2002-10-102008-08-15Cleveland Clinic Foundation DEVICE FOR REPLACING A MITRAL VALVE WITH A STENTLESS BIOPROSTHETIC VALVE WITH CHORDAE
US7748389B2 (en)*2003-12-232010-07-06Sadra Medical, Inc.Leaflet engagement elements and methods for use thereof
US7597711B2 (en)*2004-01-262009-10-06Arbor Surgical Technologies, Inc.Heart valve assembly with slidable coupling connections
US20060195183A1 (en)2005-02-182006-08-31The Cleveland Clinic FoundationApparatus and methods for replacing a cardiac valve
US7955385B2 (en)2005-02-282011-06-07Medtronic Vascular, Inc.Device, system, and method for aiding valve annuloplasty
US20060195186A1 (en)*2005-02-282006-08-31Drews Michael JConnectors for two piece heart valves and methods for implanting such heart valves
SE531468C2 (en)2005-04-212009-04-14Edwards Lifesciences Ag An apparatus for controlling blood flow
CA2606101A1 (en)2005-04-252006-11-02Evalve, Inc.Device and methods for endoscopic annuloplasty
WO2007130880A1 (en)*2006-04-292007-11-15Arbor Surgical Technologies, IncGuide shields for multiple component prosthetic heart valve assemblies and apparatus and methods for using them
CA2654314A1 (en)*2006-06-012007-12-06Mor Research Applications Ltd.Methods and devices for treatment of cardiac valves
EP2072027B1 (en)2007-12-212020-06-17Medtentia International Ltd Oypre-annuloplasty device and method
US8845722B2 (en)2009-08-032014-09-30Shlomo GabbayHeart valve prosthesis and method of implantation thereof
US20110224785A1 (en)2010-03-102011-09-15Hacohen GilProsthetic mitral valve with tissue anchors
AU2011275468B2 (en)2010-07-092014-02-06Highlife SasTranscatheter atrio-ventricular valve prosthesis
US9132009B2 (en)*2010-07-212015-09-15Mitraltech Ltd.Guide wires with commissural anchors to advance a prosthetic valve
CN103476362A (en)2011-01-112013-12-25汉斯·赖纳·菲古拉 Valve prostheses used to replace heart arterioventricular valves
EP2478868A1 (en)2011-01-252012-07-25The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen ElizabethImplant device
US10500038B1 (en)2011-05-202019-12-10Tel Hashomer Medical Research Infrastructure And Services Ltd.Prosthetic mitral valve, and methods and devices for deploying the prosthetic mitral valve
US9364326B2 (en)2011-06-292016-06-14Mitralix Ltd.Heart valve repair devices and methods
US8852272B2 (en)2011-08-052014-10-07Mitraltech Ltd.Techniques for percutaneous mitral valve replacement and sealing
US9763780B2 (en)2011-10-192017-09-19Twelve, Inc.Devices, systems and methods for heart valve replacement
US9078747B2 (en)2011-12-212015-07-14Edwards Lifesciences CorporationAnchoring device for replacing or repairing a heart valve
CA3095260C (en)2012-01-312023-09-19Mitral Valve Technologies SarlMitral valve docking devices, systems and methods
US11156041B2 (en)2012-02-222021-10-26Richard Paul PosaSystem and method for treating water
EP2948100B1 (en)2013-01-252021-05-05Medtentia International Ltd OyA system for cardiac valve repair
JP6600558B2 (en)2013-01-252019-10-30メドテンシア インターナショナル エルティーディー オーワイ Device, medical system and method for collection of chordae and / or leaflets
CA2898989C (en)2013-01-252021-03-23Medtentia International Ltd OyA removable implantable non-indwelling valve
US9439763B2 (en)2013-02-042016-09-13Edwards Lifesciences CorporationProsthetic valve for replacing mitral valve
CN105263442B (en)2013-02-042019-02-15托尔福公司 Hydraulic delivery system and related methods for prosthetic heart valve devices
EP2805695A1 (en)2013-05-212014-11-26Medtentia International Ltd OyMedical system for annuloplasty
US9662202B2 (en)2013-10-242017-05-30Medtronic, Inc.Heart valve prosthesis
US9700412B2 (en)2014-06-262017-07-11Mitralix Ltd.Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices
EP3174502B1 (en)2014-07-302022-04-06Cardiovalve LtdApparatus for implantation of an articulatable prosthetic valve
US10292850B2 (en)2014-11-042019-05-21Cook Medical Technologies LlcDeployment handle for a prosthesis delivery device
AU2016205371B2 (en)2015-01-072019-10-10Tendyne Holdings, Inc.Prosthetic mitral valves and apparatus and methods for delivery of same
US10470876B2 (en)2015-11-102019-11-12Edwards Lifesciences CorporationTranscatheter heart valve for replacing natural mitral valve
US10583007B2 (en)2015-12-022020-03-10Edwards Lifesciences CorporationSuture deployment of prosthetic heart valve
EP3399947B1 (en)2016-01-072024-12-25Medtronic Vascular, Inc.Prosthetic valve with flow director
US10722359B2 (en)2016-08-262020-07-28Edwards Lifesciences CorporationHeart valve docking devices and systems
FR3060292B1 (en)2016-12-152019-01-25Cmi'nov DEVICE FOR REALIZING OR PREPARING MITRAL ANNULOPLASTY BY TRANSFEMORAL PATHWAY
PT3554424T (en)2016-12-162023-04-03Edwards Lifesciences CorpDeployment systems, tools, and methods for delivering an anchoring device for a prosthetic valve
US10743991B2 (en)2017-01-232020-08-18Edwards Lifesciences CorporationChordae tendineae adjustment
US20190083242A1 (en)2017-09-192019-03-21Cardiovalve Ltd.Systems and methods for implanting a prosthetic valve within a native heart valve
US11090153B2 (en)2017-10-132021-08-17W. L. Gore & Associates, Inc.Telescoping prosthetic valve and delivery system
JP7072062B2 (en)2017-10-312022-05-19ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド Transcatheter placement system and related methods
JP7410942B2 (en)2018-10-292024-01-10キヤノン ユーエスエイ,インコーポレイテッド Support structure for medical devices and manufacturing method thereof
JP7555919B2 (en)2018-11-142024-09-25シェバ インパクト リミテッド Atrioventricular valve repair
CA3149527A1 (en)2019-08-142021-02-18Innovalve Bio Medical Ltd.Atrioventricular valve replacement
EP4236872B8 (en)2020-10-272025-01-08Sheba Impact Ltd.Atrioventricular valve frame with opposing sets of arms
CN116507298A (en)2020-10-272023-07-28堤乐哈修门医学研究基础建设及服务有限公司 Transcatheter Deployment of Medical Devices Without the Use of a Nose Cone
US20240238089A1 (en)2021-05-052024-07-18Innovalve Bio Medical Ltd.Delivery device
WO2022264082A1 (en)2021-06-172022-12-22Tel Hashomer Medical Research, Infrastructure And Services Ltd.Valve frame for prosthetic tricuspid valve
WO2023228028A1 (en)2022-05-222023-11-30Sheba Impact Ltd.Atrioventricular valve repair
CN119730814A (en)2022-09-132025-03-28因诺韦尔弗生物医疗有限公司Implantable frame

Patent Citations (39)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20030014104A1 (en)*1996-12-312003-01-16Alain CribierValue prosthesis for implantation in body channels
WO2000060995A2 (en)1999-04-092000-10-19Evalve, Inc.Methods and apparatus for cardiac valve repair
US7018408B2 (en)*1999-12-312006-03-28Abps Venture One, Ltd.Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US20070050020A1 (en)2000-02-022007-03-01Spence Paul AHeart valve repair apparatus and methods
US20020065554A1 (en)2000-10-252002-05-30Streeter Richard B.Mitral shield
US20040138745A1 (en)2001-10-012004-07-15Ample Medical, Inc.Methods and devices for heart valve treatments
US7621948B2 (en)2003-07-212009-11-24The Trustees Of The University Of PennsylvaniaPercutaneous heart valve
US20100042208A1 (en)2003-07-212010-02-18The Trustees Of The University Of PennsylvaniaPercutaneous Heart Valve
WO2005087140A1 (en)2004-03-112005-09-22Percutaneous Cardiovascular Solutions Pty LimitedPercutaneous heart valve prosthesis
US20120010461A1 (en)2004-09-272012-01-12Abbott Vascular Inc.Methods and devices for tissue grasping and assessment
CN101180010A (en)2005-05-242008-05-14爱德华兹生命科学公司 rapid deployment prosthetic heart valve
US20070016288A1 (en)*2005-07-132007-01-18Gurskis Donnell WTwo-piece percutaneous prosthetic heart valves and methods for making and using them
WO2007135101A1 (en)2006-05-182007-11-29Edwards Lifesciences AgDevice and method for improving heart valve function
US20080039935A1 (en)2006-08-142008-02-14Wally BuchMethods and apparatus for mitral valve repair
DE102006052564B3 (en)2006-11-062007-12-13Georg LutterMitral valve stent for surgical implantation and fixation of heart valve prosthesis to heart, has stent clips arranged distally, where one of stent clips forms section that is externally rolled in unfolded condition of stent
US20100022640A1 (en)2006-12-202010-01-28Donald Wesley StoutamireEsters of 2-phenylalkanenitriles and antifungal compositions containing them
US8070802B2 (en)2007-02-232011-12-06The Trustees Of The University Of PennsylvaniaMitral valve system
US7753949B2 (en)2007-02-232010-07-13The Trustees Of The University Of PennsylvaniaValve prosthesis systems and methods
US20100249923A1 (en)2007-09-282010-09-30St Jude Medical Inc.Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features
US20090192585A1 (en)2008-01-242009-07-30Medtronic, Inc.Delivery Systems and Methods of Implantation for Prosthetic Heart Valves
US20090192586A1 (en)2008-01-242009-07-30Medtronic, Inc.Delivery Systems for Prosthetic Heart Valves
JP2011509806A (en)2008-01-242011-03-31メドトロニック,インコーポレイテッド Delivery system and method for implantation of a prosthetic heart valve
WO2009134701A2 (en)2008-05-012009-11-05Edwards Lifesciences CorporationDevice and method for replacing mitral valve
US20100049313A1 (en)2008-08-222010-02-25Edwards Lifesciences CorporationProsthetic heart valve and delivery apparatus
JP2012500665A (en)2008-08-222012-01-12エドワーズ ライフサイエンシーズ コーポレイション Prosthetic heart valve and delivery device
CN102292053A (en)2008-09-292011-12-21卡迪尔克阀门技术公司Heart valve
US20120101571A1 (en)2008-11-212012-04-26Percutaneous Cardiovascular Solutions Pty LimitedHeart valve prosthesis and method
CN102438546A (en)2008-11-212012-05-02经皮心血管解决方案公司 Prosthetic heart valve and method
WO2010108079A1 (en)2009-03-192010-09-23Millipede LlcReconfiguring heart features
JP2012521222A (en)2009-03-192012-09-13ミリピード リミテッド ライアビリティー カンパニー Reconstruction of cardiac features
US20110137397A1 (en)2009-12-042011-06-09Edwards Lifesciences CorporationProsthetic valve for replacing mitral valve
US8870950B2 (en)2009-12-082014-10-28Mitral Tech Ltd.Rotation-based anchoring of an implant
US20110137410A1 (en)2009-12-082011-06-09Hacohen GilFoldable hinged prosthetic heart valve
US20150045880A1 (en)2009-12-082015-02-12Mitraltech Ltd.Implant for rotation-based anchoring
US20110264208A1 (en)2010-04-272011-10-27Medtronic, Inc.Prosthetic Heart Valve Devices and Methods of Valve Repair
US20120022640A1 (en)2010-07-212012-01-26Yossi GrossTechniques for percutaneous mitral valve replacement and sealing
WO2012095116A1 (en)2011-01-112012-07-19Hans Reiner FigullaValve prosthesis for replacing an atrioventricular valve of the heart
WO2013175468A2 (en)2012-05-202013-11-28Tel Hashomer Medical Research Infrastructure And Services Ltd.Prosthetic mitral valve
US20150173897A1 (en)2012-05-202015-06-25Tel Hashomer Medical Research Infrastructure And Services Ltd.Prosthetic mitral valve

Non-Patent Citations (20)

* Cited by examiner, † Cited by third party
Title
Advisory Action Before the Filing of an Appeal Brief dated Mar. 1, 2018 From the U.S. Patent and Trademark Office Re. U.S. Appl. No. 14/402,387. (4 pages).
Applicant-Initiated Interview Summary dated Dec. 28, 2017 From the U.S. Patent and Trademark Office Re. U.S. Appl. No. 14/402,387 (3 pages).
Applicant-Initiated Interview Summary dated May 25, 2017 From the U.S. Patent and Trademark Office Re. U.S. Appl. No. 14/402,387. (3 pages).
Communication Pursuant to Article 94(3) EPC dated Jan. 8, 2018 From the European Patent Office Re. Application No. 13732633.6. (5 Pages).
Communication Relating to the Results of the Partial International Search dated Nov. 18, 2013 From the International Searching Authority Re. Application No. PCT/IL2013/050432.
Examination Report dated Dec. 20, 2017 From the Australian Government, IP Australia Re. Application No. 2013264730. (4 Pages).
Examination Report dated Jan. 13, 2017 From the Australian Government, IP Australia Re. Application No. 2013264730. (4 Pages).
Final Official Action dated Mar. 5, 2014 From the U.S. Patent and Trademark Office Re. U.S. Appl. No. 13/083,643.
International Preliminary Report on Patentability dated Dec. 4, 2014 From the International Bureau of WIPO Re. Application No. PCT/IL2013/050432.
International Search Report and the Written Opinion dated Feb. 26, 2014 From the International Searching Authority Re. Application No. PCT/IL2013/050432.
Notice of Amendment dated Jun. 23, 2017 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201710425696.6 and Its Machine Translation Into English. (2 Pages).
Notice of Reason for Rejection dated Feb. 14, 2017 From the Japan Patent Office Re. Application No. 2015-513347. (3 Pages).
Notification of Office Action and Search Report dated Sep. 7, 2016 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0.
Notification of Office Action dated Dec. 14, 2016 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0 and Its Translation Into English. (4 Pages).
Notification of Office Action dated Dec. 3, 2015 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0.
Official Action dated Dec. 23, 2016 From the U.S. Patent and Trademark Office Re. U.S. Appl. No. 14/402,387. (25 pages).
Official Action dated Oct. 2, 2017 From the U.S. Patent and Trademark Office Re. U.S. Appl. No. 14/402,387. (27 pages.
Translation dated Dec. 28, 2015 of Notification of Office Action dated Dec. 3, 2015 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0.
Translation of Notice of Reason for Rejection dated Feb. 14, 2017 From the Japan Patent Office Re. Application No. 2015-513347. (15 Pages).
Translation of Notification of Office Action and Search Report dated Sep. 7, 2016 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201380038199.0.

Cited By (38)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20230320847A1 (en)*2008-05-012023-10-12Edwards Lifesciences CorporationProsthetic heart valve assembly
US12115065B2 (en)*2008-05-012024-10-15Edwards Lifesciences CorporationProsthetic heart valve assembly
US12208003B2 (en)2011-05-202025-01-28Sheba Impact Ltd.Prosthetic mitral valve
US12097114B2 (en)2012-05-202024-09-24Tel Hashomer Medical Research Infrastructure And Services Ltd.Ventricular structure reshaping atrio-ventricular valve
US11779459B2 (en)2012-05-202023-10-10Tel Hashomer Medical Research Infra And Svcs LtdFrame for prosthetic valve
US11406497B2 (en)2013-03-142022-08-09Jc Medical, Inc.Heart valve prosthesis
US11938024B2 (en)*2013-03-142024-03-26Jc Medical, Inc.Methods and devices for delivery of a prosthetic valve
US11259923B2 (en)*2013-03-142022-03-01Jc Medical, Inc.Methods and devices for delivery of a prosthetic valve
US20220183824A1 (en)*2013-03-142022-06-16Jc Medical, Inc.Methods and devices for delivery of a prosthetic valve
US11207177B2 (en)*2015-11-062021-12-28Micor LimitedMitral valve prosthesis implantation
US11304799B2 (en)2015-11-062022-04-19Micor LimitedMitral valve prosthesis
US10966824B2 (en)2015-11-062021-04-06Micor LimitedMitral valve prosthesis delivery system
US11331187B2 (en)*2016-06-172022-05-17Cephea Valve Technologies, Inc.Cardiac valve delivery devices and systems
US11672643B2 (en)2016-09-072023-06-13Daniel Ezra WalzmanEndovascular device with expandable filter
US12138149B2 (en)2016-09-072024-11-12Daniel Ezra WalzmanEndovascular devices and methods with filtering elements
US11642211B2 (en)2016-09-072023-05-09Daniel Ezra WalzmanLasso filter tipped microcatheter for simultaneous rotating separator, irrigator for thrombectomy and method for use
US11642210B2 (en)2016-09-072023-05-09Daniel Ezra WalzmanLasso filter tipped microcatheter for simultaneous rotating separator, irrigator for thrombectomy and method for use
US12414774B2 (en)2016-09-072025-09-16Daniel Ezra WalzmanFilterless aspiration, irrigating, macerating, rotating microcatheter and method of use
US11439492B2 (en)*2016-09-072022-09-13Daniel Ezra WalzmanLasso filter tipped microcatheter for simultaneous rotating separator, irrigator for thrombectomy and method for use
US12369932B2 (en)2016-09-072025-07-29Daniel Ezra WalzmanMethods and devices to ameliorate vascular obstruction
US11877752B2 (en)2016-09-072024-01-23Daniel Ezra WalzmanFilterless aspiration, irrigating, macerating, rotating microcatheter and method of use
US12171649B2 (en)2016-09-072024-12-24Daniel Ezra WalzmanLasso filter tipped microcatheter for simultaneous rotating separator, irrigator for thrombectomy and method for use
US12167956B2 (en)2016-09-072024-12-17Daniel Ezra WalzmanLasso filter tipped microcatheter for simultaneous rotating separator, irrigator for thrombectomy and method for use
US12161543B2 (en)2016-09-072024-12-10Daniel Ezra WalzmanEndovascular device with expandable filter
US11666444B2 (en)2017-08-032023-06-06The Regents Of The University Of CaliforniaAtrial cage for placement, securing and anchoring of atrioventricular valves
US11020226B2 (en)2018-01-072021-06-01Jc Medical, Inc.Prosthetic heart valve delivery system
US11331184B2 (en)2018-01-072022-05-17Jc Medical, Inc.Methods and devices for delivery of a prosthetic valve
US12376962B2 (en)2018-01-072025-08-05Jc Medical, Inc.Methods and devices for delivery of a prosthetic valve
US12350156B2 (en)2018-11-142025-07-08Sheba Impact Ltd.Atrioventricular valve repair
US11883640B2 (en)2019-02-062024-01-30inQB8 Medical Technologies, LLCIntra-cardiac left atrial and dual support systems
US10888644B2 (en)2019-02-062021-01-12inQB8 Medical Technologies, LLCIntra-cardiac left atrial and dual support systems
US12138157B2 (en)2019-08-142024-11-12Innovalve Bio Medical Ltd.Atrioventricular valve replacement
US12036115B2 (en)2019-08-142024-07-16Innovalve Bio Medical Ltd.Atrioventricular valve replacement
US12396847B2 (en)2019-08-142025-08-26Innovalve Bio Medical Ltd.Atrioventricular valve replacement
CN111067667A (en)*2019-12-272020-04-28先健科技(深圳)有限公司 Force measuring device and its push assembly
US20210205073A1 (en)*2020-01-082021-07-08Cephea Valve Technologies, Inc.Multi-component Valve Implant and Delivery Methods
EP3848001A1 (en)*2020-01-082021-07-14Cephea Valve Technologies, Inc.Multi-component valve implant and delivery methods
CN115399917A (en)*2021-11-052022-11-29瀚芯医疗科技(深圳)有限公司Artificial chordae tendineae implanting device

Also Published As

Publication numberPublication date
US11583394B2 (en)2023-02-21
US20250120805A1 (en)2025-04-17
US12208003B2 (en)2025-01-28
US20230172707A1 (en)2023-06-08
US20200046491A1 (en)2020-02-13

Similar Documents

PublicationPublication DateTitle
US12208003B2 (en)Prosthetic mitral valve
US20230190460A1 (en)Prosthetic heart valve docking assembly
JP7341199B2 (en) System and method for transcatheter treatment of valve regurgitation
US12097114B2 (en)Ventricular structure reshaping atrio-ventricular valve
US11083581B2 (en)Expandable heart valve coaptation device
KR102566728B1 (en) Heart valve sealing device and delivery device therefor
JP6942652B2 (en) System for heart valve replacement
JP2024503697A (en) Heart valve sealing device and delivery device therefor
JP5848345B2 (en) Transcatheter atrioventricular valve prosthesis
CN110664514B (en)Convoluted anchor for supporting a prosthetic heart valve, prosthetic heart valve and deployment device
JP6773416B2 (en) Artificial valve for mitral valve replacement
JP2020531178A (en) Artificial heart valve with tethered joint
JP2019507664A (en) Heart valve replacement system and method
CN108348321A (en)Heart valve
JP2017505208A (en) Heart valve fixation device
CN104768500A (en) Heart Valve Sealing Device
US20190321173A1 (en)Flexible heart valve prosthesis
US20240268808A1 (en)Tissue puncture sealing devices and methods
HK40079503A (en)Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
HK40020238A (en)Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
HK40020238B (en)Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device

Legal Events

DateCodeTitleDescription
STCFInformation on status: patent grant

Free format text:PATENTED CASE

FEPPFee payment procedure

Free format text:ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

MAFPMaintenance fee payment

Free format text:PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment:4


[8]ページ先頭

©2009-2025 Movatter.jp